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ABSTRACT 
 Satellite cells (SCs) are mononuclear myogenic stem cells located between the 
basal lamina and plasmalemma of the skeletal muscle fiber.  They are responsible for 
postnatal skeletal muscle growth, repair and regeneration.  Once activated, SCs divide 
and fuse to the muscle fibers where their nuclei become new myonuclei.  Earlier 
studies suggested that SCs were either randomly or evenly distributed along muscle 
fibers.  However, myonuclei were found to be more concentrated at tapered ends of 
muscle fibers.  Myogenic regulatory factors, mainly MyoD and Myogenin, are 
expressed by active SCs.  Previous in vitro and prenatal studies suggested that MyoD 
expression demarcates the end of proliferation while Myogenin can demarcate the 
differentiation stage within myoblasts.  Few in vivo studies have reported the 
expression of MyoD and Myogenin within SCs, and none have attempted to discern 
their expression patterns during growth.  Meat producing chickens represent a unique 
model for natural hypertrophy within muscle fibers.  However, very little is known 
about the distribution of SCs within these naturally hypertrophied fibers, and whether 
this distribution is comparable to that of experimental models of hypertrophy.  
Nandrolone Decanoate is the anabolic steroid most commonly used to increase 
skeletal muscle mass and strength, although little is known of its effects on SCs.  This 
thesis expands our understanding of SCs by examining the following hypotheses: 1) 
there is a greater frequency (number of SC nuclei over all nuclei within the basal 
laminae) and a higher concentration (less surface area of sarcolemma per SC) of SCs 
at the ends of developing skeletal muscle fibers, 2) MyoD and Myogenin 
transcription myogenic factors have distinctive patterns of expression within SC 
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nuclei during maturation, 3) there are greater frequency and concentration of SCs and 
greater number of myonuclei in naturally hypertrophied muscle fibers compared to 
their control, and 4) there is a greater frequency and a greater concentration of SCs in 
Nandrolone treated birds than in controls.  Chicken pectoralis muscle was the main 
experimental model used in this thesis because of its overlapping fibers arranged in 
series, the presence of neonatal myosin at the fiber ends and relative homogeneity of 
fiber type.  Immunocytochemical techniques that include an antibody against Pax7 to 
identify SC nuclei were applied, and computer image analyses were then used to 
quantify the numbers of SC nuclei and myonuclei within muscle fibers.  This thesis 
demonstrates that throughout development there is a greater frequency and 
concentration of SCs at the ends of developing skeletal muscle fibers, which indicates 
a major contribution of these cells in the longitudinal growth of muscle fibers.  It also 
reveals that MyoD and Myogenin each has a distinctive pattern of expression within 
SCs during in vivo postnatal development.  The expression of MyoD increases 
significantly during maturation, while Myogenin expression remains steady.  This 
finding suggests that each of these myogenic factors play a different role in the 
postnatal activation of SCs.  Lastly, it is the first study to show a greater frequency 
and a higher concentration of SCs within both naturally and Nandrolone induced 
hypertrophied muscle fibers.  This indicates SCs may be critically involved  during 
postnatal skeletal muscle growth and hypertrophy. 
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 1.1 Satellite cells 
Muscular tissue is considered one of the four basic tissues in the body.  It is 
further divided into three types of muscles; smooth, cardiac and skeletal.  Smooth 
muscles are found around hollow tubes in the body, such as the intestines, and have a 
high regeneration capability through either division or differentiation.  Cardiac 
muscle forms most of the heart and is considered to have no capacity for 
regeneration.  Skeletal muscles are the main part of the muscular tissue and are 
responsible for movement and support.  The regeneration capability of skeletal 
muscles has been described as limited, and due to a specific population of progenitor 
adult stem cells known as satellite cells (SCs; Gray and Carter 2005; Gartner and 
Hiatt 2007). 
 
 SCs are mononucleated myogenic stem cells located between the basal lamina 
and plasmalemma of the skeletal muscle fiber, and are responsible for postnatal 
muscle growth and regeneration (Muir 1970; Morgan and Partridge 2003; Mckinnell 
et al. 2005).  SCs were discovered in 1961 by Mauro and Katz while studying the 
skeletal muscles of the frog (Mauro 1961; Katz 1961).  The SC is fusiform-shaped 
with a central nucleus, with its long axis directed along the length of the muscle fiber   
(Fig. 1).  A SC can reach 25 µm in length but is less than 5 µm in width, and 
possesses elongated cytoplasmic tails at each end (Muir 1970; Castillo de Maruenda 
and Franzini-Armstrong 1978; Novotova and Uhrik 1991). 
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Figure 1: A satellite cell (SC) and myonuclei within a muscle fiber.  This diagram 
shows from deep to superficial, the plasmalemma, basal lamina and endomysium 
layers that cover the muscle fiber.  Myonuclei are located within the fiber beneath the 
plasmalemma, while the SC is sandwiched between the plasmalemma and basal 
lamina. 
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During myogenesis, myogenic precursors differentiate from mesodermal cells 
of the somite and migrate to their final destination.  After that, myoblasts start fusing 
together to form myotubes which become muscle fibers.  Some of these myogenic 
precursors do not differentiate into myotubes, but instead reside beneath the muscle 
fiber basal lamina to become SCs after birth (Hawke and Garry 2001; Mckinnell et al. 
2005; Zammit et al. 2006a).  It is unclear whether SCs originate from the somite as a 
distinct lineage of myogenic precursors, or as a preexisting lineage such as embryonic 
or fetal myoblasts.  It has also been suggested that SCs can develop from a 
non-somitic origin such as endothelial cells or a precursor common to both SCs and 
endothelial cells (De Angelis et al. 1999, Seale and Rudniki 2000). 
 
 SCs can be recognized based on their distinctive position between the basal 
lamina and plasmalemma of the muscle fiber.  An immunostaining technique can be 
used to outline the plasmalemma (by labeling the dystrophin protein; McLoon et al. 
2004), basal lamina (by labeling the glycoprotein laminin; Halevy et al. 2004), and all 
nuclei (by using a DNA stain such as DAPI or Hoechst).  Any nucleus between the 
plasmalemma and basal lamina is defined as a SC nucleus.  In addition to this 
location, many protein and molecular markers have been used to identify SCs.  The 
paired box transcription factor seven (Pax7) has been one of the most common 
markers used for this purpose.  Pax7 is a highly conserved protein that belongs to the 
helix-turn-helix class of transcription factors.  It was found to be expressed 
specifically in cells residing beneath the basal lamina in positions characteristic for 
SCs (Seale et al. 2000; Collins et al. 2005; Relaix et al. 2005; Allouh and Rosser 
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2006).  SCs were also absent in Pax7 null mice, which suggests a crucial role for 
Pax7 in specification of SCs (Seale et al. 2000).  Pax7 is found to be up-regulated in 
SCs that exit the cell cycle and yet escape differentiation (Olguin and Olwin 2004).  
Other markers used to label SCs include M-Cadherin, myocyte nuclear factor and 
CD34 (Morgan and Partridge 2003).  The advantages of Pax7 over other markers are 
that it is expressed in all SC nuclei and effective antibodies are readily available 
(Zammit et al. 2006a). 
 
 During postnatal growth, SCs are usually active.  They undergo proliferation 
and differentiation by fusing to growing muscle fibers where their nuclei become new 
myonuclei (Morgan and Partridge 2003; Halevy et al. 2004).  In adult life, however, 
SCs are quiescent.  In response to injury of muscle fibers, SCs may become active 
and start expressing myogenic regulatory factors.  They migrate to the site of injury 
and enter the proliferation and differentiation cycle again where they fuse to the 
injured muscle fibers or, to a lesser extent, fuse together forming new fibers.  
Nevertheless, some of these proliferating SCs do not differentiate but return to 
quiescence as a self renewal mechanism (Fig. 2; Hawke and Gary 2001; Zammit et al. 
2006a). 
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Figure 2: The life cycle of satellite cells (SCs).  SCs are usually quiescent and 
located beneath the fiber’s basal lamina.  Under an appropriate stimulus, they become 
active and start to express the different myogenic factors.  Their cytoplasmic volume 
increases significantly with well developed organelles.  After that, SCs start to 
proliferate, and then differentiate by either fusing to a preexisting fiber or by fusing 
together to form a new fiber.  Eventually, SC nuclei become new myonuclei.  
However, a small proportion of proliferated SCs will not differentiate.  Instead they 
return to quiescence to reestablish the pool of SCs. 
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 The molecular mechanism for activation of SCs starts by the synthesis of 
nitric oxide (NO) from L-arginine within injured muscle fibers (Reid 1998; Anderson 
2000; Wozniak et al. 2005).  NO reacts on its cytoplasmic receptor guanylyl cyclase 
to produce cyclic guanylyl monophosphate (Ignarro et al. 1980; Wedel and Garbers 
2001).  This leads to the release of hepatocyte growth factor (HGF).  HGF then binds 
to its c-met receptors on the surface of SCs, which initiates the mitogen-activated 
protein kinase pathway and the phosphatidyl inositol 3 kinase pathway (Cornelison 
and Wold 1997; Furge et al. 2000; Wozniak et al. 2005).  These two pathways induce 
the transcription and translation of myogenic regulatory factors and other 
transcriptional factors required for activation and proliferation of SCs (Kami et al. 
1995; Wozniak et al. 2005). 
 
The distribution and frequency of SCs (number of SC nuclei over myonuclei 
and SC nuclei) in skeletal muscles has been correlated with several factors such as 
species, age, type of muscle fiber and presence of specific anatomic structures like 
motor end plates and blood capillaries.  For example, the frequency in sartorius 
muscle of the pig was found to be 0.01 (Hawke and Gary 2001), while in frog 
sartorius it was 0.10 (Castillo de Maruenda and Franzini-Armstrong 1978).  While 
SCs constitute about 30% of muscle nuclei in newborn rodents, this ratio is decreased 
to 4% in adults and 2% in senile animals (Snow 1977).   
 
The frequency of SCs is different among fiber types, as within each species 
studied there are more SCs in red (oxidative) fibers than in white (glycolytic) fibers 
 8
(Gibson and Schultz 1983).  The myonuclear density of the red fibers is greater than 
that of white fibers, which means red fibers possess more nuclei than white fibers of 
the same size (Schultz and McCormick 1994; Tseng et al. 1994; Schmalbruch and 
Lewis 2000).  The exact reason why red fibers require more nuclei is not known, but 
it could be related to a higher metabolic activity and higher protein remodeling rate in 
red than white fibers.  The SC population in a muscle always reflects the requirement 
for myonuclei production (Schultz and McCormick 1994).  Since the mitotic rate 
(activity) of SCs in both types of fibers is similar, the only compensatory measure to 
add more myonuclei in red fibers is to have additional SCs (Schultz and McCormick 
1994).  
 
SCs are more concentrated near specific anatomic structures such as motor 
end plates and blood capillaries (Schultz and McCormick 1994).  Previous studies 
state that SCs are either evenly (Snow 1981) or randomly (Novotova and Uhrik 1991) 
distributed along the fiber length with greater numbers near motor endplates. 
However, some of these studies (Snow 1981) mention that the number of SCs around 
myoneural junctions is not large enough to significantly affect the mean percentages 
of SCs.  Other work indicates that SCs are more numerous near blood capillaries 
(Schmalbruch and Hellhammer 1977), as are myonuclei (Ralston et al. 2006).  
Nonetheless, many questions remain concerning the distribution of SCs in muscle 
fibers. 
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1.2 The myonuclear domain 
Skeletal muscle fibers are comparatively large cells where a single fiber can 
have a total volume of several microliters.  The muscle fiber maintains its large 
volume of sarcoplasm by having hundreds to thousands of nuclei.  An earlier study 
had suggested that products of myonuclei can mix in the muscle fiber (Frair and 
Peterson 1983).  However, later experiments have suggested that most of the proteins 
are locally synthesized, processed and distributed within fibers (Pavlath et al. 1989; 
Ralston and Hall 1989; Rotundo 1990).  This later suggestion supports the theory of 
myonuclear domain, where each myonucleus is responsible for gene expression 
within its surrounding portion of sarcoplasm. 
 
The size of the myonuclear domain is the volume of sarcoplasm that is 
associated with a single myonucleus.  It has been suggested that myonuclear domain 
size is correlated with the skeletal muscle fiber type and the rate of protein synthesis 
during development (Edgerton and Roy 1991).  Previous studies have found a smaller 
domain size in slow type I fibers than fast type II fibers (Edgerton and Roy 1991; 
Tseng et al. 1994; Kasper and Xun 1996b).  This is due to the smaller fiber size and 
higher myonuclear number in slow type I fibers. 
 
Regarding the rate of protein synthesis, there is disagreement in the literature 
on whether the domain size changes during muscle development.  Some studies have 
claimed that during postnatal development the number of myonuclei increases to 
maintain a constant myonuclear domain size (Moss 1968; Winchester and Gonyea 
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1992; Allen et al. 1995).  Other studies indicate that despite the increase in 
myonuclear number, the domain size also increases during normal development 
(Knizetova et al. 1972; Mozdziak et al. 1994, 1997). 
 
 
1.3 Expression of myosin heavy chain isoforms 
The myosin protein, which forms the thick myofilaments in skeletal muscle 
fibers, is composed of two heavy chains and four light chains (Lowey 1994; Tidyman 
et al. 1997).  It makes up more than 50% of skeletal muscle protein (Craig and Padron 
2005).  Myosin thick filaments constitute a major component of the muscle 
contractile unit.  It is well established that muscle contraction occurs through binding 
of the heads of myosin heavy chains with thin actin filaments (Craig and Padron 
2005). 
 
Skeletal muscle fibers are classified based on their myosin heavy chain 
(MyHC) isoform complement (Schiaffino and Reggiani 1996; Spangenburg and 
Booth 2003).  Slow type I fibers contain type I myosin, while type II fast-twitch 
fibers contain type II MyHC isoform.  In mature mammalian muscle, type II fibers 
are further subclassified into type IIa, type IIb and type IIx fibers.  Each of these 
fibers contains a specific MyHC isoform that determines the velocity of contraction 
and ATPase activity within the fiber (Weiss et al. 1999; Talmadge 2000; Pette and 
Staron 2001).  The speed of muscle fiber contraction according to MyHC isoform is 
described as IIb > IIx > IIa > I.  In mammals, during development, there is also an 
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embryonic and a neonatal isoform that are subsequently replaced by these mature 
adult isoforms. 
 
Avian skeletal muscles contain both fast and slow MyHC isoforms.  The fast 
isoforms include three embryonic, a neonatal and an adult isoform (Tidyman et al. 
1997).  During development, only few muscles replace the embryonic and neonatal 
isoforms by the adult isoform.  Other avian muscles never express the adult isoform, 
instead they retain either the embryonic or the neonatal isoform (Bandman and 
Rosser 2000).   
 
Distinct MyHC isoforms are sequentially expressed in chicken pectoralis 
muscle during various stages of development.  Embryonic isoforms are directly 
replaced by the neonatal isoform that is in turn gradually replaced by an adult isoform 
(Bandman et al. 1994; Rosser et al. 1995; Bandman and Rosser 2000).  These 
isoforms are functionally related, but differ in their biochemical structure due to some 
variation in amino acid sequence.  The myosin transformation process in the fibers of 
chicken pectoralis is initiated near the centrally located motor end plate and 
progresses towards the fiber tapered ends (Rosser et al. 2000).  As the adult isoform 
starts to be expressed during the early post-hatch period, some regions between adult 
and neonatal myosin overlap.  These regions can be defined as transforming (Rosser 
et al. 2000).  In later post-hatch development, the neonatal isoform is progressively 
restricted to and retained within the tapered ends of chicken pectoralis fibers (Fig. 3). 
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 As the transformation begins centrally in the thicker regions of the fibers, and 
progresses to the more peripheral tapered ends, the adult fiber profiles seen in a 
cross-section of the muscle represent the central regions of the fiber, and the neonatal 
profiles are the fiber ends.  The transforming profiles are from regions between these 
adult and neonatal profiles.  The fiber profiles show the following gradation in size: 
adult > transforming > neonatal (Rosser et al. 2000, 2002).  
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Figure 3: Transformation of myosin heavy chain isoforms within chicken pectoralis.  
At age 30 days post-hatch, the adult myosin isoform starts to replace the neonatal 
isoform near the centrally located motor end plate.  The transformation process 
progresses with age toward fiber ends until the neonatal isoform is restricted to the 
fiber tapered ends near maturation.  The regions that contain both isoforms where the 
transformation process is still underway are defined as transforming regions. 
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1.4 Anabolic androgenic steroids 
Anabolic Androgenic Steroids (AAS) are synthetic drugs that mimic the 
primary male sex hormone testosterone.  Testosterone is responsible for both the 
androgenic and anabolic effects that take place during puberty and continue in 
adulthood.  The androgenic effects of testosterone during puberty include the 
activation of the male reproductive system and the development of secondary male 
sexual characteristics such as hair distribution and deepening of the voice.  The 
anabolic effects include an increase in height and an increase in muscle mass and 
strength.  AAS are the consequence of research to develop drugs that would separate 
the anabolic capability of testosterone from its androgenic properties.  However, this 
separation has never been fully achieved and no purely anabolic agent has ever been 
synthesized (Kochakian 1976; Gunes and Fetil 2000; Clark and Henderson 2003). 
 
There are over 100 AAS available (Sullivan et al. 1999).  They all share the 
same basic chemical structure of a four-ring carbon skeleton.  The main differences in 
chemical structure are the number of carbon atoms attached to number 17 carbon 
atom in the skeleton and the manner of how hydrogen, oxygen and hydroxyl groups 
are attached to carbon atoms.  These chemical differences have been induced to 
enhance the anabolic effects and reduce the androgenic properties of these drugs 
(Wright and Cowart 1990).  
 
 AAS are lipid soluble molecules that can pass easily through membranes to 
bind to their androgenic receptors within the nucleus.  Nuclear androgenic receptors 
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are transcription factors with a ligand binding domain and a DNA binding domain.  
Binding of AAS to their receptors regulates the transcriptional activity of these 
receptors, which in turn regulates the expression of several target genes (Cooper and 
Hausman 2004).  Within skeletal muscle tissue, androgenic receptors have been 
found in both myonuclei and SC nuclei (Sinha-Hikim et al. 2004).  This finding 
supports the suggestion that AAS are acting through more than one mechanism to 
enhance the growth of skeletal muscle fibers. 
 
  AAS have been classified into three categories based upon their interaction 
with nuclear androgenic receptors (Saartok et al. 1984).  The first includes AAS that 
bind with high affinity to androgen receptors.  These steroids are described as strong 
androgens, and include most of the synthesized forms of testosterone.  The second 
category represents steroids that bind with low affinity to androgen receptors.  These 
steroids, like stanozolol, are described as weak androgenic substances.  The third 
category contains those AAS that do not bind to androgen receptors at all.  These 
steroids act after biotransformation to other compounds.  Oxymetholone is an 
example of this group of steroids (Toth and Zakar 1982; Saartok et al. 1984). 
 
The exact molecular mechanism of action of AAS is not completely 
understood and still subject to research.  Several mechanisms and theoretical models 
of action have been suggested.  For example, the enzyme 5-α-reductase has been 
recognized as playing an important role in the action of AAS (Wilson 1988).  This 
enzyme converts most AAS into the more active compound dihydrotestosterone 
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within target cells.  5-α-reductase activity is located primarily in male sex glands, 
skin and fat cells.  However, skeletal muscle possesses low 5-α-reductase activity 
(Wilson 1988).  Another suggested molecular mechanism of AAS action within 
skeletal muscle is the enhanced transcription of insulin-like growth factor 1 (IGF-1) 
by the AAS-receptor complex (Lang and Frost 2002).  IGF-1 then acts via two 
mechanisms to enhance skeletal muscle growth and hypertrophy.  First, IGF-1 
increases protein synthesis within muscle by activating translational initiation 
(Bodine et al. 2001).  Second, IGF-1 inhibits p27 cyclin-dependent kinase inhibitor 
protein thereby signaling SCs to proliferate (Chakravarthy et al. 2000).  The p27 
protein inhibits cyclin-dependent kinase 2, which is a necessary enzyme for 
transmitting SCs toward the proliferation stage. 
 
 AAS abuse exerts many side effects including both physiological and 
behavioral problems.  These side effects are mainly related to the dosage, duration 
and type of steroid being taken (Wu 1997).  The physiological problems include 
cardiovascular effects, such as cardiomyopathy and impaired diastolic function 
(Kennedy and Lawrence 1993; Sullivan et al. 1999).  Also, raised blood pressure is 
one of the most common side effects of AAS misuse (Lenders et al. 1988; Perry et al. 
1990).  Another physiological problem related mainly to chronic abuse of oral 
steroids is liver toxicity.  Nearly all studies of AAS users have documented 
abnormalities in liver function (Hickson et al. 1989; Friedl 1993; Yesalis and Cowart 
1998).  Boada et al. (1999) studied the hepatic effects of high doses of the anabolic 
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steroid stanozolol in rats.  They found that the liver exhibited inflammatory and 
degenerative lesions in centrilobular hepatocytes.  
 
 The most noticed behavioral side effect of AAS abuse is aggression leading to 
violent outbursts (Pope and Katz 1990; Corrigan 1996).  Steroid abusers usually 
become very aware of their surroundings, and this heightened awareness can 
sometimes lead to schizophrenic and psychotic episodes (Annitto and Layman 1980; 
Choi and Pope 1994; Stanley and Ward 1994).  Also, AAS users generally report an 
increased sexual drive (Lenehan et al. 1996).  It is believed that the androgenic effects 
of the steroids enhance this sexual desire (Moss et al. 1993). 
 
 The most popularly used injectable steroid is Nandrolone Decanoate, which is 
also known as Deca Durabolin.  Nandrolone causes muscle to store more nitrogen 
than it releases, so a positive nitrogen balance is achieved.  The positive nitrogen 
balance is synonymous with muscle growth because it allows the muscle fiber to 
accumulate a larger amount of protein than usual (Van Wayjen 1993).  Since its 
initial discovery in 1970s, Nandrolone has been used in the treatment of several 
clinical conditions, and is also used by athletes to enhance their competitive 
capabilities (Wright 1982; Lenehan 2003; George 2005).   
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 SCs play a critical role during post-natal growth, repair and regeneration of 
skeletal muscles.  Their function and distribution depend on several factors such as 
fiber type, age and the situation in which they are active or quiescent.  However, 
despite the vast body of ongoing research in this field, investigations are still required 
in a number of areas regarding SCs.  This thesis examined four main aspects of SCs 
in developing skeletal muscle fibers. 
 
The specific aims are: 
1) To delineate the distribution of SCs both temporally and spatially during 
development.  It is hypothesized that the frequency of SCs is decreased with age, and 
there is a greater frequency and a greater concentration of SCs at the ends of muscle 
fibers.  Anti-Pax7 antibody was used to identify SC nuclei in their characteristic 
positions beneath muscle fibers basal laminae in the chicken pectoralis muscle.  The 
frequency of SCs with age, and the frequency and concentration of SCs along the 
fibers length were then measured. 
 
2) To clearly characterize the in vivo expression patterns of both MyoD and 
Myogenin myogenic regulatory factors by SC nuclei during growth.  It is 
hypothesized that MyoD and Myogenin transcription factors have distinctive patterns 
of expression within SC nuclei during maturation.  The percentages of SCs that 
express MyoD and/or Myogenin within chicken pectoralis muscle were obtained 
from several ages during post-hatch development until adulthood.  The percentages of 
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myonuclei that express MyoD and/or Myogenin were also obtained from the same 
ages. 
 
3) To determine the frequency and concentration of SCs within hypertrophied 
muscles of meat producing chickens that represent a natural model of hypertrophy.  It 
is hypothesized that there are a greater frequency and concentration of SCs and 
greater number of myonuclei in hypertrophied muscle of a natural model.  A 
secondary aim is to compare the distribution of SCs in this natural model with other 
experimental models of hypertrophy studied previously.  
 
4) To better understand the effects of the anabolic steroid Nandrolone Decanoate on 
the distribution of SCs, and to determine its effects on the morphology of skeletal 
muscle fibers such as fiber size, the distribution of myonuclei and size of myonuclear 
domains.  The thesis tests the hypothesis that Nandrolone administration leads to 
increased muscle mass and fiber size within the growing chicken pectoralis, and the 
hypothesis that there is a greater frequency and a greater concentration of SCs in 
Nandrolone treated birds than in the controls.  The frequency and concentration of 
SCs were measured in the pectoralis muscle of two groups of chickens.  The first 
group received Nandrolone injections and the second received normal saline as a 
control.  In addition to SC distribution, muscle weight, fiber size and size of 
myonuclear domains were measured and compared between Nandrolone treated and 
control groups. 
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3.1 Introduction 
Satellite cells (SCs) are mononuclear myogenic cells located between the 
basal lamina and plasmalemma of the skeletal muscle fiber (Mauro 1961; Schultz and 
McCormick 1994; Wozniak et al. 2005).  They contribute to skeletal muscle growth, 
regeneration and repair (Lemischka 1999; Charge and Rudnicki 2004).  Under proper 
stimuli, such as injury to the muscle fiber or exercise, SCs can become active, 
proliferate and fuse with the fiber to become new myonuclei (Moss and Leblond 
1971; Seale and Rudnicki 2000; Hawke and Garry 2001).  The paired box 
transcription factor seven (Pax7) is expressed by quiescent, active and proliferating 
SCs, but is not expressed by myonuclei (Seale et al. 2000; Collins et al. 2005; Relaix 
et al. 2005).  Pax7 is an upstream transcriptional activator of the myogenic regulatory 
factor MyoD, and also plays a critical anti-apoptotic role in activated SCs (Reliax et 
al. 2006).  The specific expression of Pax7 by all SCs in the pectoralis muscle of 
chicken was confirmed in a previous study (Halevy et al. 2004).  
 
The frequency of SCs, which is the number of SC nuclei divided by the sum 
of myonuclei and SC nuclei, has been used to study the distribution of SCs in skeletal 
muscles (Schmalbruch and Helhammer 1977; Gibson and Schultz 1983; Hikida et al. 
1998; Roth et al. 2000; Sajko et al. 2002).  This frequency of SCs was found to vary 
among species (Castillo de Maruenda and Franzini-Armstrong 1978; Novotova and 
Uhrik 1992) and muscles with different fiber types (Schmalbruch and Hellhammer 
1977; Schultz and McCormick 1994).  However, the trend in temporal distribution for 
most species and muscles studied showed a decrease in SC number and frequency 
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with age.  For example, while SCs comprise about 30% of muscle nuclei in newborn 
rodents, this percent decreases to about 4% in adults and 2% in senile animals (Snow 
1977; Gibson and Schultz 1983; Hawke and Garry 2001).  Many questions remain 
concerning the spatial distribution of SCs within skeletal muscles.  Previous studies 
have shown that SCs tend to be more concentrated near specific anatomic structures, 
such as blood capillaries and motor end plates (Schultz and McCormick 1994).  
Along the rest of the length of individual muscle fibers, SCs have been described as 
either evenly (Snow 1981) or randomly (Novotova and Uhrik 1992) distributed.  
 
The ends of skeletal muscle fibers have been shown to be comparatively 
active sites of postnatal growth.  New sarcomeres are added in series to the ends of 
existing myofibrils during normal longitudinal growth of the muscles of mammals 
(Goldspink 2003) and fish (Ennion et al. 1999).  In mouse muscles in which fibers are 
arranged in series, longitudinal growth of the fibers also produces an increase in the 
diameter of the muscle (Paul and Rosenthal 2002).  Nuclei are preferentially added to 
the ends of growing myotubes in rats (Zhang and Mclennan 1995).  Rosser et al. 
(2002) have previously shown that myonuclei are more concentrated at the ends of 
maturing fibers of post-hatch chicken pectoralis.  In experimentally induced 
lengthening of immature leg muscle of rabbits, a greater proportion of SCs expressing 
proliferating cell nuclear antigen were located at the musculotendinous junction than 
in other regions of the muscle (Tsujimura et al. 2006). 
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The pectoralis muscle of the chicken is composed of fibers that overlap one 
another in series from the origin to the insertion of the muscle (Gaunt and Gans 1992, 
Trotter 1993).  Consequently, a transverse section anywhere through the belly of the 
muscle will include many fiber ends (Rosser et al. 1995, 2000, 2002).  Distinct 
myosin heavy chain (MyHC) isoforms are sequentially expressed within the fibers of 
developing chicken pectoralis (Bandman and Rosser 2000).  Embryonic isoforms are 
supplanted by a neonatal isoform that is in turn replaced by an adult isoform.  In each 
muscle fiber, replacement of neonatal by adult MyHC isoform progresses from the 
centrally located motor end plate towards the tapered ends of the fiber (Rosser et al. 
2000).  Fiber ends invariably have the smaller diameters, and retain densities of 
neonatal myosin comparable to those observed in neonatal muscle (Rosser et al. 
1995, 2000, 2002).  
   
This study elucidates the temporal and spatial patterns of SC distribution in 
the post-hatch chicken pectoralis.  It tests the hypothesis that there is a greater 
frequency and concentration of SCs at the ends of muscle fibers.  The same chicken 
pectoralis samples used in the previous studies of Rosser et al. (2000, 2002) are 
examined.  Using immunocytochemical techniques that include an antibody against 
Pax7, SCs are detected among different regions of the muscle fibers during 
maturation.  While the frequency of SCs is significantly reduced with age, it remains 
high at the ends of the fibers where SCs are also located closer to one another. 
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3.2 Materials and Methods 
3.2.1 Experimental Model 
Female White Leghorn chickens (Gallus gallus; Hy-Line W-36, Clark Hy-
Line, Brandon, Manitoba) were hatched at the same time and raised under identical 
conditions at the University of Saskatchewan, Department of Animal and Poultry 
Science as described previously in Rosser et al. (2002).  It has already been 
established that chickens reach sexual maturity around the age of 150 days post-hatch 
(Limburg 1975).  Following the Canadian Council on Animal Care Guidelines, and 
with the approval of the University of Saskatchewan Committee on Animal Care and 
Supply, three birds were killed by cervical dislocation at each of the following ages; 
9, 23, 30, 49, 62, 79 and 115 days post-hatch. 
 
3.2.2 Tissue Preparation and Sectioning 
 Three muscle samples were excised from the cranial half of the superficial 
region of the main part of the left pectoralis muscle (M. pectoralis pars 
sternobrachialis; Vanden Berge and Zweers 1993) of each bird.  Each sample was 
approximately 0.5 x 0.5 x 1-2 cm.  The long axis of each sample was parallel to the 
direction of the muscle fibers.  Each sample was then coated with O.C.T. compound 
(Miles Inc., Indiana, USA) and immediately frozen in 2-methylbutane cooled via 
liquid nitrogen (Sewry and Dubowitz 2001).  After that, samples were stored at 
-80oC. 
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Serial cross-sections of 10 μm thickness were cut at -20oC using a cryostat.  
Two serial sections were picked up on each ProbeOn Plus microscopic slide (Fisher 
Scientific Ltd., Ontario, Canada).  Serial slides bearing sections were numbered and 
stored at -20oC.  Along with these cross sections, some longitudinal sections were 
obtained in order to measure the length of SC nuclei. 
 
3.2.3 Antibodies and Nuclear Labeling Agent 
 The previously characterized primary antibodies used for immunostaining 
were anti-Pax7, anti-laminin and anti-neonatal myosin heavy chain.  All were diluted 
in blocking solution (see following).  Anti-Pax7 (Developmental Studies Hybridoma 
Bank, Iowa, USA; Berggren et al. 2001), a mouse monoclonal developed against 
chicken Pax7, was used at a dilution of 1:100 to detect SC nuclei.  Anti-laminin 
(L9393, Sigma Chemical Co., Missouri, USA; Tisay and Key 1999) a rabbit 
polyclonal raised against the glycoprotein laminin of mice, was used at 1:200 to 
detect the basal lamina of skeletal muscle fibers.  The anti-neonatal MyHC (2E9, gift 
from Dr. E. Bandman), a mouse monoclonal developed against chicken neonatal 
MyHC isoform (Bandman 1985; Moore et al. 1992), was used at 1:500.  Depending 
on the density of labeling by the anti-neonatal MyHC antibody, it was possible to 
distinguish three different fiber profile types; neonatal, transforming and adult (see 
following).   
 
Fluorescein isothiocyanate-conjugated anti-mouse and tetramethyl rhodamine 
anti-rabbit secondary antibodies (A-11010 and A-11001, Molecular Probes, Oregon, 
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USA) were used to detect, respectively, anti-Pax7 (green) and anti-laminin (red) 
when viewed with epifluorescent microscopy.  Each of these secondary antibodies 
was prepared at a dilution of 1:200 in phosphate-buffered saline (PBS; 0.02 M 
sodium phosphate buffer, 0.15 M sodium chloride, pH 7.2).  Biotin-conjugated anti-
mouse secondary antibody (B-9904, Sigma Chemical Co., Missouri, USA) was used 
at a dilution of 1:500 in another set of experiments to visualize labeling of neonatal 
myosin by the anti-neonatal MyHC antibody when viewed under bright-field 
microscopy.  Hoechst 33258 (Bisbenzimide, 10 mg/ml stock concentration, Sigma 
Chemical Co., Missouri, USA) was applied at a dilution of 1:1,500,000 in PBS to 
label the DNA in nuclei (blue) under epifluorescent microscopy.    
 
3.2.4 Immunocytochemical Techniques 
 Serial numbered slides were removed from the freezer and air dried for 15 
minutes.  Sections were treated for 30 minutes with at least 200 μl of blocking 
solution, which consisted of 5mM ethylenediaminetetraacetic acid (EDTA) in PBS, 
5% goat serum and 1% bovine serum albumin.  Blocking solution was drained from 
each slide onto a paper towel. 
 
Slides were then alternatively treated either with the anti-neonatal MyHC 
antibody for bright-field microscopy or with anti-Pax7, anti-laminin and Hoechst for 
epifluorescent microscopy.  Using this approach the type of fiber profile (neonatal, 
transforming or adult) was identified on one slide, while SC nuclei and myonuclei 
within the same fiber were located in the serial sections on the adjacent slide. 
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3.2.4.1 Bright-Field Immunocytochemistry 
 The anti-neonatal MyHC was applied over the sections using 150 µl on each 
slide for 70 minutes at room temperature.  Slides were then washed twice in fresh 
PBS solution for five minutes per wash.  The biotinylated goat anti-mouse secondary 
antibody was then applied over the sections on each slide for 30 minutes at room 
temperature, followed by two five minutes washes in fresh PBS solution.   
 
Slides were then placed in 3% hydrogen peroxide in methanol for five 
minutes followed by two five minutes washes in PBS.  Next 150 μl of Avidin ABC 
kit (Vector Laboratories Inc., California, USA) diluted in PBS was applied over the 
sections that were then kept in the dark for 60 minutes.  Slides were then washed in 
phosphate buffer solution (PB; 0.02 M sodium phosphate buffer, pH 7.2) twice for 
five minutes each.  To obtain a specific color reaction visible under the bright-field 
microscope, slides were immersed in 0.05% diaminobenzidine in PB for five minutes.  
This was followed by a five minutes wash in PB, and then a five minute wash in PBS.   
 
Slides were then fixed with 4% formaldehyde in PBS solution for three 
minutes, and then washed for five minutes in fresh PBS.  After that, slides were 
rinsed for five minutes under tap water.  Finally, the wet slides were mounted with 
cover slips using Geltol mounting medium (Thermo Shandon, Pennsylvania, USA) 
and left for 20 minutes to harden before being examined under the microscope.  
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3.2.4.2 Epifluorescent Immunocytochemistry 
Anti-Pax7 and anti-laminin primary antibodies were diluted in blocking 
solution and applied together over the sections on slides using 150 μl per slide.  The 
slides were kept overnight in the dark at 4oC.  Next morning, slides were washed 
three times in fresh PBS solution for five minutes per wash.  A cocktail containing 
the fluorescein and tetramethyl secondary antibodies A-11010 and A11001 was then 
applied over the sections on each slide for 30 minutes at room temperature.  This was 
followed by two five minutes washes in fresh PBS solution.  Hoechst 33258 diluted 
1:1,500,000 in PBS was applied over the sections for five minutes, followed by two 
additional five minutes washes in PBS.  Slides were then fixed with 4% 
formaldehyde in PBS, and mounted in Geltol as described in the preceding section.  
 
3.2.5 Image Analysis and Data Collection 
 Three fields of view, each having entirely different fiber profiles, were 
captured from each immunofluorescent slide using a Zeiss Axioskop 20 microscope 
(Carl Zeiss GmbH, Jena, Germany) equipped for epifluorescence and a Sony S70 
(Sony Corporation, Tokyo, Japan) digital still camera.  Three epifluorescent images, 
each viewed through a different wavelength filter, were acquired from each field.  
The resultant images were all nuclei in blue, SC nuclei in green and basal laminae in 
red (Fig. 1).  Images were subsequently transferred to a Macintosh G4 computer 
(Apple Computers Inc., California, USA) and the three images for each field of view 
were superimposed using Adobe Photoshop (Adobe System Inc., California, USA).   
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Images of the anti-neonatal MyHC antibody labeled slides were taken under 
bright-field microscopy from sections serial to those used for epifluorescence, and 
included the same fields of view that were photographed under epifluorescence    
(Fig. 1).  These bright-field images were then transferred to the computer and, using a 
graphic converter program (Lemke Software GmbH, Peine, Germany), image format 
was changed to TIFF format.  Scion imaging program (developed by US National 
Institute of Health; Image J is the current version that is available on the internet at 
http://rsb.info.nih.gov/ij) was then used to set the images to gray scale for measuring 
the optical density and the ellipse minor axis of individual fibers.  
 
The optical density and ellipse minor axis of 200 contiguous fiber profiles 
from each animal were measured.  Optical density measurements were used to 
classify fiber profiles as neonatal, transforming or adult.  White and black were 
automatically assigned optical density values of 0 and 255, respectively, at the ends 
of an arithmetic linear regression (r2 = 1.00).  Pectoralis tissue from 9 day old chicks 
was used as a neonatal density control, since it contains only neonatal myosin 
(Bandman and Rosser 2000).  Larger fiber profiles of pectoralis tissue from 115 day 
old chickens were used as a control for the absence of neonatal myosin (Rosser et al. 
2000 and 2002).  All fiber profiles quantified at age 9 days had optical densities of 
>110, while control adult profiles at age 115 days had values of <80.   Thus, in all 
sections studied fiber profiles with a density of >110 were classified as neonatal, 
profiles <80 were classified as adult, and profiles ≥80 and ≤110 were classified as 
transforming.  Ellipse minor axis was used to assess the size of fiber cross sectional 
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profiles from the pectoralis of birds aged 9, 49 and 62 days.  These fiber profiles were 
then arranged into groups according to size by 10 µm increments.  Rosser et al. 
(2000) have previously shown that ellipse minor axis is identical to lesser fiber 
diameter, which was defined as the maximum aspect across the lesser aspect of a 
fiber.  Lesser fiber diameter is used to overcome distortion that may result when a 
muscle fiber is cut obliquely, rather than transversely (Dubowitz 1985). 
 
The numbers of satellite cell nuclei (SCN) and myonuclei (MN) within each 
of the 200 fibers of each animal were totaled.  After that, the frequency of SCs was 
calculated for each animal, for each fiber profile type and for each fiber size range 
group using the formula that frequency = (SCN / SCN+MN) X 100% (Schmalbruch 
and Helhammer 1977).  The mean values for SC frequency per fiber type and size 
group were obtained from three animals at each age. 
 
The lengths of SC nuclei were measured from the longitudinal sections 
obtained from three animals at each of the following ages; 9, 30, 49, 62 and 115 days.  
Applying the same protocol used to label Pax7 within the cross sections, the lengths 
of 15-22 SC nuclei from each animal were measured using the Scion imaging 
program.  The average length of SC nuclei was calculated for each age, and the mean 
value of the averages was determined.  
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 The number of SCs per unit length of fiber was calculated for each type of 
fiber profile (neonatal, transforming and adult) using a formula from Castillo de 
Maruenda and Franzini-Armstrong (1978).  This formula is N= A/(Ln + M), where N 
is the number of SCs per unit length of fiber, A is the mean number of SC nuclei per 
fiber profile, Ln is the average length of SC nucleus and M is the thickness of tissue 
section.  The surface area of the plasmalemma per unit length of the fiber was also 
measured for different profiles using the formula S= πEU, where S is the surface area 
of the plasmalemma per unit length of fiber, E is the ellipse minor axis and U is the 
unit length of the fiber (1 mm).  Lastly, the area of muscle fiber plasmalemma per 
each SC was determined by dividing the surface area measurements (S) by the 
number of SCs (N) in each type of fiber profile. 
 
3.3 Statistics 
 After determining the homogeneity of variance, data were evaluated by one-
way and univariate analysis of variance (ANOVA) at 5% level of significance.  The 
samples were blocked into different age groups and randomized complete block 
design analysis was applied.  If a significant (P < 0.05) difference was found, 
Scheffe’s post hoc analysis test was applied to examine statistical differences between 
groups.  Kruskal-Wallis non-parametric test was used to evaluate surface area per SC 
data, and t-test for two independent samples was further applied to compare the 
neonatal group along with transforming or adult group.  All statistical tests were 
performed using SPSS program (standard version 12.0.0, SPSS Inc., Illinois, USA). 
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Figure 1: Immunocytochemical labeling of transverse serial sections of chicken 
pectoralis. Chicken pectoralis aged 9 (A, B, C), 49 (D, E, F) and 79 (G, H, I) days 
post hatch.  A, D and G are viewed by bright-field and labeled by the anti-neonatal 
MyHC antibody to distinguish the type of fiber profile (neonatal=N, transforming=T 
and adult=A).  B, E and H are, respectively, sections cut serial to A, D and G viewed 
under epifluorescence.  All nuclei appear blue due to labeling by Hoechst, and basal 
laminae red with labeling by anti-laminin.  C, F and I are the same sections as B, E 
and H, respectively, showing satellite cell nuclei in green labeled by anti-Pax7 and 
the basal laminae in red labeled by anti-laminin. 
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3.4 Results 
3.4.1 Expression of Pax7 by SC nuclei  
 
The locations of Pax7 labeled (+) nuclei relative to basal laminae were 
determined from three animals at each of four different developmental ages; 9, 49, 62 
and 115 days post hatch (Table 1).  It was found that about 97-98% of the Pax7+ 
nuclei were located beneath the basal lamina.  Consequently, these nuclei were 
classified as SC nuclei.  The remaining 2-3% were nuclei located outside of the basal 
lamina in the surrounding endomysium and perimysium (Fig. 2). 
 
3.4.2 Length of SC Nuclei 
 Mean length of SC nuclei was determined on longitudinal sections obtained 
from three animals at each of the following ages; 9, 30, 49, 62, 115 days post hatch 
(Table 2).  There were no significant (P > 0.05) differences in the mean length of SC 
nuclei either within or among these ages.  Thus, there is a uniform length for SC 
nuclei in chicken pectoralis during development. The overall mean length was 10.28 
μm ± 0.10 (± standard deviation).   
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Age (days) 
 
9 49 62 115 
Number of fibers 1,500 1,680 1,650 1,485 
Pax7+ nuclei within 
basal laminae 
159 161 144 103 
Pax7+ nuclei outside 
basal laminae  
3 5 4 2 
% of Pax7+ SC nuclei 98.15% 96.99% 97.30% 98.10% 
% of Pax7+ non-SC 
nuclei 
1.85% 3.01% 2.70% 1.90% 
 
 
 
Table 1: Percent of Pax7+ nuclei that are satellite cell (SC) nuclei.  “Number of 
fibers” for each age listed represents the total number of fibers analyzed from three 
birds.  Approximately 500 fibers per animal were analyzed at each age.  The percent 
of Pax7+ nuclei that are SC nuclei (located beneath the basal laminae) was calculated.  
At each age a small percentage of the Pax7+ nuclei were found in locations not 
characteristic of SCs. 
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Figure 2: Pax7+ nucleus outside of the basal laminae.  A cross section prepared from 
pectoralis muscle of a 49 day old chicken and labeled for immunofluorescence by 
Hoechst in blue (A), anti-Pax7 in green (B) and anti-laminin in red (A and B).  The 
arrowheads indicate a Pax7+ nucleus that is located outside of the fibers’ basal 
laminae within the interstitial tissue of the muscle.  
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Table 2: Length of satellite cell (SC) nuclei.  Longitudinal sections were cut from 
three birds at each of the five ages.  The lengths of 15 to 22 SC nuclei were measured 
from each bird.  Each value represents the average of the means from three birds at 
each age ± standard error (SE).  There was no significant (P > 0.05) difference in the 
lengths of SC nuclei among the different aged birds studied. The mean length of SC 
nuclei in the five ages was found to be 10.28 μm ± 0.06 (SE). 
 
 
 
 
 
 
 
 
 
Age 
(days) 
9 30 49 62 115 
Mean Length 
of SC nuclei 
(μm) ± SE 
10.30  
± 0.06 
10.17 
 ± 0.03 
10.33 
 ± 0.07 
10.40 
 ± 0.06 
10.18 
 ± 0.09 
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3.4.3 Frequency of SCs with Age 
The mean frequency of SCs decreased significantly (P < 0.01) with age.  As 
illustrated in Figure 3, the frequency declined from 20.04% at age 9 days to 4.86% at 
115 days post hatch.  These findings were consistent with previous results of Halevy 
et al. (2004), and reflect observations from studies of other species (Hawke and Garry 
2001).  Furthermore, this data showed that the declining pattern of SC frequency with 
age is a curvilinear regression (SC frequency= 34.129-6.091 Ln [age], r2= 0.953).  
 
3.4.4 Frequency of SCs with Type of Fiber Profile 
 By correlating the frequency of SCs to the type of fiber profile (neonatal, 
transforming or adult) it was found that the highest frequency was among the 
neonatal profiles.  SC frequency in neonatal profiles ranged from 13.65% to 20.04% 
during development.  The frequency of SCs was dramatically (P < 0.001) decreased 
with repression of neonatal MyHC isoform expression (Fig. 4).  There was no 
significant difference (P > 0.05) in SC frequency between transforming and adult 
profiles.  Overall, the mean frequency of SCs in transforming and adult profiles never 
reached 10%.  All fiber profiles at ages 9 and 23 days were neonatal, while most of 
the profiles at age 115 days were adult.  The transforming profiles appear somewhere 
between 23 and 30 days of age (see Rosser et al. 2000).  These findings support the 
current study’s hypothesis that there is a greater frequency of SCs at the ends of 
muscle fibers, as after 23 days of age neonatal profiles are in fact the tapered ends of 
the fibers (Rosser et al.  2000). 
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Figure 3: Satellite cell (SC) frequency during development.  The frequency of SCs,  
(SCN/SCN+MN)x100%, in pectoralis muscle of the chicken was determined for 
three birds at each of the following ages; 9, 23, 30, 49, 62, 79 and 115 days post 
hatch.  Numbers of SC nuclei (SCN) and myonuclei (MN) were counted separately 
for 200 contiguous fibers per each muscle sample.  Each symbol represents the mean 
SC frequency (%) ± standard error (SE).  The percentage of SC frequency is 
significantly (one-way ANOVA, P < 0.01) decreased with age.   
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Figure 4: Satellite cell (SC) frequency during development in neonatal, transforming 
and adult fiber profiles.  Each column represents mean SC frequency (%) + standard 
error (SE).  The frequency is significantly (P < 0.001) greater in neonatal profiles 
than in either transforming or adult profiles at all ages examined.  After 23 days of 
age, the neonatal profiles are the ends of more mature transforming and adult profiles 
(Rosser et al. 2000).  * At age 115 days the frequency of SCs within adult profiles is 
significantly (P < 0.05) lower than the frequency within transforming profiles and 
adult profiles at all ages. 
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3.4.5 Frequency of SCs with Size of Fiber Profile 
 The mean frequency of SCs decreased with increasing fiber size.  The ellipse 
minor axis of the largest profiles at age 9 days did not exceed 20 μm.  At this age 
although fibers ranging from 0-10 µm had a greater frequency of SCs than those 
ranging from 10.01-20 µm, this difference was not statistically significant (P = 0.12, 
Fig. 5A).  At age 49 days and 62 days there was a significant (P < 0.01) decrease in 
the mean frequency of SCs as the ellipse minor axis increased (Fig. 5B, C).  This 
decrease was most prominent as the ellipse minor axis increased from the range of 
0.0-10.00 μm to 10.01-20 μm.  These findings strongly support the hypothesis that 
the tapered fiber ends have a higher frequency of SCs, since the smaller fiber profiles 
seen at the age of 49 and 62 days are the tapered ends of muscle fibers (see Rosser et 
al.  2000).   
 
3.4.6 Surface Area of Sarcolemma per SC 
 The surface area of muscle fiber sarcolemma per SC was calculated for each 
different type of fiber profile at each of the following ages; 9, 49, 62, 79, 115 days 
post hatch.  There was less area of sarcolemma per SC in neonatal profiles than in 
other profiles (Fig. 6).  The difference was statistically significant (P < 0.05) between 
neonatal and either transforming or adult profiles, but not between transforming and 
adult profiles (P = 0.38).  These results show that there is a greater concentration of 
SCs at fiber ends, represented by neonatal profiles, than in other regions of the 
muscle fibers. 
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Figure 5: Correlation of satellite 
cell frequency with fiber size.  
Three birds were studied at three 
different ages; (A) 9 days, (B) 49 
days and (C) 62 days.  Between 
200-250 fiber cross sections from 
each pectoralis studied were 
arranged into different groups 
according to their ellipse minor 
axes values.  Each column 
represents mean SC frequency 
(%) + standard error (SE).  The 
frequency of SCs in ages 49 and 
62 days is significantly (P < 0.01) 
reduced with increasing fiber 
size.  The smaller fiber profiles 
are the tapered ends of larger 
profiles (Rosser et al. 2000).  In 
each age graph, columns with 
different letters are statistically 
different (Scheffe’s, P < 0.05). 
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Figure 6: Correlation of surface area of sarcolemma per satellite cell (SC) with 
different types of fiber profiles during development.  Each column represents mean 
surface area of sarcolemma x 103 μm2 + standard error (SE).  There is significantly  
(P < 0.05) less surface area per SC in neonatal profiles than transforming or adult 
profiles.  * At age 115 days, the surface area per SC in adult profiles is significantly 
(P < 0.05) larger than that in transforming profiles and adult profiles at all ages. 
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3.5 Discussion 
 
This study reveals new information about the temporal and spatial patterns of 
SC distribution.  It is the first work to demonstrate that throughout growth and 
maturation there is both a greater frequency and a higher concentration of SCs at the 
terminal tips of skeletal muscle fibers.  Earlier works showed that the ends of 
maturing skeletal muscle fibers in the post-hatch pectoralis of the chicken (Rosser et 
al. 2000) and pigeon (Bartnik et al. 1999) retain high densities of neonatal MyHC 
isoform.  The current study finds that while SC frequency decreases during 
development with repression of neonatal MyHC isoform expression along the fiber 
lengths, the tapered fiber ends retaining neonatal myosin also keep a high frequency 
of SCs.  To further validate these results the frequencies of SCs for different sizes of 
fiber profiles were obtained, and a higher frequency of SCs was found in smaller fiber 
profiles.  This corroborates the results correlating greater SC frequency with the 
expression of neonatal myosin, as the smaller fiber profiles are the tapered ends of 
skeletal muscle fibers (Rosser et al. 2000).  A greater concentration of SCs at the ends 
of skeletal muscle fibers was also observed, as shown by significantly less area of 
plasmalemma per SC in those fiber regions expressing neonatal myosin. 
 
Developing skeletal muscle fibers grow in both length and width (Zhang and 
McLennan 1995; Paul and Rosenthal 2002).  It has been established that the terminal 
ends of maturing muscle fibers are the regions for longitudinal growth within the 
muscle (Swatland 1994; Goldspink 2003).  Earlier work showed that smaller 
myonuclear domains are present at the tapered ends of the fibers in the post-hatch 
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chicken pectoralis (Rosser et al. 2002).  Myonuclear domain is the volume of 
sarcoplasm associated with a single myonucleus, and each myonucleus is responsible 
for protein synthesis within its domain (Hall and Ralston 1989; Allen et al. 1999).  
Smaller myonuclear domain can be an indication of greater protein synthesis, since 
myonuclei tend to be more concentrated in regions of active protein synthesis 
(Edgerton and Roy 1991; Winchester and Gonyea 1992; Allen et al. 1999; Ohira et al. 
2001).  Myonuclei arise from SCs (Seale and Rudnicki 2000; Hawke and Garry 
2001).  Presumably the higher frequency and concentration of SCs now observed at 
the fiber ends is correlated with the demand for more myonuclei there, due to greater 
protein synthesis required for longitudinal growth.  Nevertheless, further study is 
required to determine whether SCs at the fiber ends are quiescent or active.  A study 
of mouse fast and slow-twitch muscles has revealed that while SC numbers fall with 
age, their myogenic potential does not (Shefer et al. 2006).  Indeed, SCs from mature 
fibers were shown to retain the ability to give rise to non-myogenic descendents 
(Asakura et al. 2001, Shefer et al. 2004).  Thus, whether they are quiescent or active, 
SCs at the ends of maturing fibers in the present study should retain their myogenic 
potential. 
 
SC nuclei have a uniform average length of approximately 10.28 μm 
throughout maturation of the post-hatch pectoralis.  This length is comparable to 
those found in previous studies of other species (Muir et al. 1970, Schmalbruch 
1977).  Earlier studies of other species and muscles found that SCs were slightly 
shorter than myonuclei (Schultz and McCormick 1994).  While this generalization 
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appears to hold for this study, the length of SC nuclei in the chicken pectoralis is not 
statistically (P = 0.55) different from the mean length of myonuclei (10.58 ± 0.08 
µm; mean ± SD) obtained from the same samples (Rosser et al. 2002).  Since SC 
nuclei become myonuclei after their differentiation and fusion to muscle fibers (Seale 
and Rudnicki 2000; Hawke and Garry 2001, Wozniak et al. 2005), it is reasonable to 
expect a similar nuclear length between SC nuclei and myonuclei.  This uniform 
nuclear length does not mean that there will be lack of variation in cell size or nuclear 
condition during the different stages of the cells (McCormick and Schultz 1994; 
Anderson 2000).  For example, a significant increase in SC cytoplasmic area 
compared with nuclear area was found during SC activation (Sinha-Hikim et al. 
2003). 
 
Pax7 is a common denominator in muscle stem cells (McKinnell et al. 2005).  
Since Pax7 is expressed in SCs during their different stages of quiescence, 
proliferation and differentiation (Seale et al. 2000; Halevy et al. 2004), this study 
depends upon Pax7 transcription factor for identification of all SC subpopulations.  
About 97-98% of Pax7+ cells are localized beneath fiber basal laminae in positions 
characteristic for SCs.  Hence, it is inferred that these Pax7+ nuclei are SC nuclei.  As 
the remaining 2-3% Pax7+ cells are located in the interstitial spaces of the muscle 
outside of the basal laminae, they are not included in the calculations for SCs.   
 
 Infrequent myogenic stem cells residing outside of the muscle fiber basement 
membrane have been identified in various studies (Tamaki et al. 2002; Dreyfus 2004; 
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Collins 2006).  The frequency of such cells is low and, thus, correlates with the 
distribution of interstitial Pax7+ cells observed in the present study.  The interstitial 
cells may be SCs in transition from one myofiber to another, as has been previously 
reported (Hughes and Blau 1990).  They could also be comparable to the progenitors 
of nascent myofibers, as has been described in chicken muscle subjected to weight 
overload (McCormick and Schultz 1992) or rapidly growing rat plantaris muscle 
(Tamaki et al. 2002).  However, earlier work has shown that small fiber profiles 
expressing neonatal myosin in maturing chicken pectoralis represent the tapered ends 
of larger fiber profiles and not nascent fibers (Rosser et al 2000). 
 
Mononucleate bone marrow derived cells can become muscle SCs (Fukada et 
al. 2002, LaBarge and Blau 2002).  These bone marrow derived cells can contribute 
to the growth and repair of muscle fibers in response to injury (Dreyfus et al. 2004) 
and normal physiologic stress (Palmero et al. 2005).  Some of these Bone Marrow 
Derived Cells are of hematopoietic origin (Camargo et al. 2003, Corbel et al 2003).  It 
has, however, been suggested that identification of the optimal hematopoietic stem 
cell for muscle regeneration remains elusive, and that these cells are unlikely to play a 
significant role under normal conditions (Sherwood et al. 2004, McKinnell et al. 
2005).  As bone marrow derived cells do not appear to express Pax7 (Asakura et al. 
2002, Collins 2006), in the present study it is unlikely that the Pax7+ nuclei found 
outside of muscle fiber basal laminae are bone marrow derived cells.  Also, as has 
been observed by studies of rat (Gavazzi et al. 1995) and a diversity of other species 
(Sigma Chemical Co.), in the present study laminin within the walls of blood vessels 
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was labeled by the anti-laminin antibody used to recognize muscle basal laminae.  In 
no instance was a Pax7+ interstitial cell ever within a blood vessel, nor did any of 
these cells appear to be associated with blood vessels. 
 
In summary, this study shows that SC frequency is significantly decreased 
during maturation of the chicken skeletal muscle.  This indicates a reduced ability of 
the muscle to grow and regenerate at older ages.  The study also reveals a higher 
frequency and a greater concentration of SCs at the tapered ends of growing skeletal 
muscle fibers.  This indicates a major contribution of these cells in the longitudinal 
growth of muscle fibers, since new sarcomeres are added to the fiber ends during 
longitudinal growth. 
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4.0 CHAPTER  
 
 
THE IN VIVO EXPRESSION PATTERNS OF MYOD AND 
MYOGENIN REGULATORY FACTORS BY SATELLITE CELL 
NUCLEI AND MYONUCLEI  
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4.1 Introduction 
Satellite cells (SCs) are mononuclear myogenic stem cells, located between 
the basal lamina and plasmalemma of the skeletal muscle fiber (Mauro 1961; Mauir 
et al. 1965; Muir 1970; Mckinnell et al. 2005).  They were discovered in 1961 
through the use of electron microscopy (Mauro 1961; Katz 1961).  SCs are highly 
active during postnatal development, where they contribute to muscle growth and 
regeneration by fusing to muscle fibers where their nuclei become new myonuclei 
(Schultz et al. 1978; Wozniak et al. 2005).  In normal mature muscle, SCs are usually 
quiescent with relatively reduced cytoplasmic volume and organelles (Schultz et al. 
1978; Hawke and Garry 2001; Wozniak et al. 2005).  Under proper stimulation, such 
as an injury to a muscle fiber or exercise, SCs become active, enter the cell cycle and 
start to proliferate.  Afterwards, most of the proliferated SCs start to differentiate by 
either fusing to a preexisting muscle fiber or, to a lesser extent, fusing together to 
form a new fiber (Bischoff 1994; Seale and Rudnicki 2000; Hawke and Garry 2001; 
Mckinnell 2005).  The remaining proliferating SCs return back to quiescence and 
maintain a reservoir of SCs.  
 
Identification of SCs can be made based upon their characteristic location 
beneath the basal lamina either by using electron microscopy or 
immunocytochemistry.  Immunocytochemistry is more commonly used, since it is 
easier to apply than electron microscopy.  Also, SCs can be identified by detecting 
specific proteins expressed only by them such as the paired box transcription factor 7 
(Pax7), M-Cadherin or CD 34 (Hawke and Garry 2001; Morgan and Partridge 2003).  
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The advantage of Pax7 is that it is expressed by SCs during all their stages: quiescent, 
proliferative and differentiated (Seale et al. 2000; Olguin and Olwin 2004; Relaix et 
al. 2005; Kuang et al. 2006).  Pax7 was found to be specifically expressed by SCs in 
rodents (Seale et al. 2000).  Similarly, the specific expression of Pax7 by all SCs in 
the pectoralis muscle of post-hatch chickens was confirmed in the previous study in 
chapter 3.0. 
 
MyoD and Myogenin are members of a specific skeletal-muscle transcription 
factor family called the myogenic regulatory factors (Funk et al. 1991; Megeney and 
Rudnicki 1995).  This family is composed of several members including MyoD, 
Myogenin, MRF4 and Myf5.  MyoD and Myogenin are considered the main members 
of this family, while Myf5 and MRF4 can carry out similar functions to MyoD and 
Myogenin respectively (Hawke and Garry 2001).  Myogenic regulatory factors are 
basic helix-loop-helix proteins that are critical for establishing the myogenic lineage 
during embryogenesis, and for controlling the terminal differentiation of myoblasts 
into myotubes (Ludolph and Konieczny 1995; Hawke and Garry 2001; Tapscott 
2005).  These factors control the expression of many muscle genes during embryonic 
and postnatal developmental stages, such as muscle structural and contractile proteins, 
nicotinic acetylcholine receptors and specific muscle enzymes such as creatine kinase 
(Nicolas et al. 1996; Hawke and Garry 2001).  
 
Several studies of MyoD and Myogenin expression in cultured myoblasts 
have suggested that these factors fulfill distinct roles in myogenesis and regeneration 
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(Sorrentino et al. 1990; Montarras et al. 1991; Cornelison and Wold 1997; Yablonka-
Reuveni et al. 1999; Cornelison et al. 2000; Yablonka-Reuveni and Paterson 2001).  
These in vitro studies reveal that MyoD expression always precedes the expression of 
Myogenin.  They have suggested a role for MyoD at the early stages of myoblast 
activation, while Myogenin expression is restricted to the late differentiation stage of 
cultured myoblasts (Montarras et al. 1991; Seale and Rudnicki 2000; Yablonka-
Reuveni and Paterson 2001).  Until now, few studies have reported the expression of 
MyoD and Myogenin in vivo by either myonuclei or satellite cell nuclei (Dedkov et 
al. 2003; Ishido et al. 2004a; 2004b).  However, these previous studies did not 
attempt to discern the patterns of expression for these factors throughout postnatal 
development. 
 
The present study tests the hypothesis that MyoD and Myogenin transcription 
factors have distinctive patterns of expression within SC nuclei during maturation.  
The chicken pectoralis muscle was the experimental model used in this study.  Two 
sets of immunofluorescence experiments were applied.  Each set included antibody 
against Pax7, to identify SC nuclei, and either an anti-MyoD or an anti-Myogenin 
antibody.  With maturation, significantly increased numbers of myonuclei and SC 
nuclei are found to express MyoD (MyoD+) until adulthood, where the numbers of 
these MyoD+ nuclei start to decline.  On the other hand, the number of SC nuclei 
expressing Myogenin (Myogenin+) is found to be nearly constant during maturation, 
while the number of Myogenin+ myonuclei increases significantly.  However, fewer 
SC nuclei and myonuclei express Myogenin in adult birds.  These findings suggest a 
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different role for each of MyoD and Myogenin within active SC nuclei during 
postnatal development. 
 
 
4.2 Materials and Methods 
4.2.1 Experimental Model 
White Leghorn chickens (Gallus gallus; Hy-Line W-36, Clark Hy-Line, 
Brandon, Manitoba) were hatched at the same time and raised under identical 
conditions at the University of Saskatchewan, Department of Animal and Poultry 
Science.  The birds were put on a 23 hours light, one-hour dark cycle at an initial 
environment temperature of 35oC.  Subsequently, temperature was decreased 3.5oC at 
weekly intervals until 21oC was reached when the birds were four weeks old.  
Feeding was done ad libitum and initially consisted of commercial chick starter that 
was replaced with a commercial chick grower (Federated Co-operatives Ltd., 
Saskatchewan, Canada) when the birds were 42 days old.  Chickens usually reach 
their sexual maturity around the age of 150 days (Limburg 1975). Following the 
Canadian Council on Animal Care Guidelines, and with the approval of the 
University of Saskatchewan Committee on Animal Care and Supply, three birds were 
killed by cervical dislocation at each of the following ages; 9, 30, 62, 79, 117 and 430 
days post-hatch.  The chicken pectoralis muscle was the model utilized in this study.   
Some special characteristics of chicken pectoralis are that its superficial regions are 
composed entirely of type IIb fibers (Rosser et al. 1996), and that myonuclei can be 
normally located within the central regions the fibers (George and Berger 1966).  
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This location made it easier to quantify myonuclei because they overly the shadows 
of the fibers, distinguishing them from interstitial non-muscle nuclei. 
 
4.2.2 Antibodies and Nuclear Labeling Agent 
 The primary antibodies used for this study were anti-Pax7, anti-MyoD and 
anti-Myogenin.  Anti-Pax7 (Developmental Studies Hybridoma Bank, Iowa, USA) is 
a mouse monoclonal antibody developed against chicken Pax7 (Berggren et al. 2001).  
It was used at a dilution of 1:100 with immunocytochemical methods to detect SC 
nuclei.  Anti-MyoD (sc-760, Santa Cruz Biotechnology Inc., California, USA) is a 
rabbit polyclonal antibody raised against a peptide corresponding to amino acids 
1-318 representing full-length MyoD protein of mouse origin.  This antibody has 
been used to detect MyoD in cultured chicken embryo myoblasts (Jiang et al. 1998).  
In this study, anti-MyoD was utilized at a dilution of 1:500 to detect MyoD+ nuclei 
by immunocytochemistry and at a dilution of 1:1000 to detect MyoD protein by 
Western analysis.  Anti-Myogenin (sc-576, Santa Cruz Biotechnology Inc., 
California, USA) is also a rabbit polyclonal antibody raised against amino acids 
1-225 representing full-length Myogenin protein of rat origin.  It was used at a 
dilution of 1:50 to detect Myogenin+ nuclei by immunocytochemistry and at a 
dilution of 1:1000 to detect Myogenin protein by Western blot analysis. 
 
Fluorescein isothiocyanate-conjugated anti-mouse (A-11010) and tetramethyl 
rhodamine anti-rabbit (A-11001) secondary antibodies (Molecular Probes, Oregon, 
USA) were used to detect anti-Pax7 (green) and either anti-MyoD or anti-Myogenin 
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(red) respectively when viewed with epifluorescent microscopy.  Each of these 
secondary antibodies was prepared at a dilution of 1:200. Also, Hoechst 33258 
(Bisbenzimide, 10 mg/ml stock concentration, Sigma Chemical Co., Missouri, USA) 
was applied at a dilution of 1:1,500,000 to label the DNA in nuclei (blue) under 
epifluorescent microscopy.  Horseradish peroxidase secondary antibody (170-6515, 
Bio-Rad Laboratories, California, USA) was used in Western blot analyses at a 
dilution of 1:10,000 to visualize labeling by the primary antibodies. 
 
4.2.3 Comparison of Amino Acid Sequencing  
 The reactivity of anti-MyoD and anti-Myogenin antibodies with chicken 
MyoD and Myogenin, respectively, was initially determined by comparing the amino 
acid sequence between these chicken proteins and those from the subjects which 
these antibodies are known to be reactive against.  The comparison was done by using 
the software programs DNA Strider 1.2 (available for free download on the internet 
by National Center for Biotechnology Information at http://www.ncbi.nlm.nih.gov, 
Marck 1988) and Clustal V (available for free download on the internet by National 
Centre for Biotechnology Information at http://www.ncbi.nlm.nih.gov, Higgins et al. 
1992).  Comparing the amino acid sequence of chicken MyoD (Lin et al. 1989; 
Yamamoto and Kuroiwa 2003) with that of human MyoD (Lingbeck et al. 2005; 
Berkes and Tapscott 2005) or mouse MyoD (Ishibashi et al. 2005; Cao et al. 2006), 
there was about 86% similarity when conserved amino acid substitutions were 
considered (Fig. 1).  Also, comparing the amino acid sequence of chicken Myogenin 
(Fujisawa-Sehara et al. 1990) with that of rat Myogenin (Wright et al. 1989) or mouse 
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Myogenin (Fujisawa-Sehara et al. 1990; Ohkawa et al. 2006), there was about 88% 
similarity when conserved amino acid substitutions were considered (Fig. 2).  These 
findings indicate that there is a good possibility for these antibodies to react with their 
corresponding chicken proteins (Dayhoff et al. 1983).  
 
4.2.4 Western Blot Analysis 
 The specificity of anti-MyoD and anti-Myogenin antibodies against their 
corresponding chicken proteins was demonstrated by Western blot analyses.  The 
protein extraction and Western protocol were performed similar to Davies et al. 
(2005) with minor modifications.  Protein samples were isolated from age 9 and 49 
days post-hatch chicken pectoralis.  Also, L8 cultured rat myoblasts were used as a 
positive control (obtained from American Type Culture Collection, Virginia, USA).  
L8 myoblast cell line was originally established in 1968 by isolation from primary rat 
skeletal-muscle cultures prepared from newborn Wistar rats (Yaffe 1968). 
 
4.2.4.1 Tissue Protein Extraction 
 Chicken pectoralis muscle samples from ages 9 and 49 days post-hatch were 
obtained and frozen at -80 oC.  Each sample, weighing approximately 100 mg, was 
transferred to a mortar placed over dry ice and crushed with a pestle into powder.  
After that, the powder sample was placed in 0.5 ml ice-cold Western lysis buffer 
(20mM HEPES, pH 7.4, 50mM KCl, 0.5mM EDTA, 0.1mM EGTA, 10% glycerol, 
1mM DTT, 1X Sigma anti-protease cocktail).  A different lysis buffer (Appendix B, 
point 1) was used in another Western blot experiment that was also applied to detect 
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the specificity of the anti-MyoD antibody (Appendix D).  The sample was then 
homogenized on ice using a Polytron homogenizer (Brinkmann Instruments, Ontario, 
Canada) for about 10 min and then sonicated over ice for 15 seconds before being 
centrifuged for 10 min at 12,128 RCFmax.  The supernatant was removed and placed 
in a fresh microtube and Bradford protein determinations were performed (Bradford 
1976). 
 
  L8 cultured rat myoblasts extract was used as a positive control for Western 
analyses.  L8 cells were collected by centrifugation with 758 RCFmax at 4 oC and the 
pelleted cells resuspended in ice-cold Western lysis buffer (20mM HEPES, pH 7.4, 
50mM KCl, 0.5mM EDTA, 0.1mM EGTA, 10% glycerol, 1mM DTT, 1X Sigma 
anti-protease cocktail). The cells were lysed using multiple freeze-thaw cycles 
followed by pulse sonication and high-speed centrifugation to remove cell debris 
(Davies et al. 2005). 
 
4.2.4.2 Gel Electrophoresis and Transblotting 
 Samples with similar protein concentration were prepared based upon 
Bradford protein assay using Bio-Rad protein reagent (Bio-Rad Laboratories) and 
bovine serum albumin (Sigma Chemical Co.) as a standard.  Equal amounts of 
protein (10 µg) from each sample were loaded on an 8% mini-gel, as was 10 µg of a 
broad range prestained protein molecular weight marker (Fermentas Life Sciences, 
Ontario, Canada).  The samples were then separated by SDS-PAGE performed with 
120 Volt at room temperature.  Following electrophoresis, the gel was removed and 
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equilibrated in a fresh transblotting buffer solution for 30 minutes at 4 oC.  The 
proteins were then transblotted from the gel onto a 0.45 µm nitrocellulose membrane 
(Pall Corporation, Missouri, USA). 
 
4.2.4.3 Western Blot Protocol 
  Each membrane was blocked with 5% molecular grade fat free skim milk 
powder (Bio-Rad Laboratories, Ontario, Canada) in phosphate-buffered saline (PBS; 
0.02 M sodium phosphate buffer, 0.15 M sodium chloride, pH 7.2) containing 0.1% 
Tween-20 (Sigma Chemical Co.) for 2 hours at room temperature.  The membrane 
was incubated overnight at 4 °C with either MyoD or Myogenin primary antibodies 
diluted 1:1000 in 5% skim milk.  The membrane was then washed twice with PBS 
containing 0.1% Tween-20 for 5 min each followed by 3 times with PBS for 5 min 
each, and then incubated for 30 minutes at room temperature with secondary antibody 
diluted 1:10,000 in 5% skim milk.  An enhanced chemiluminescence detection 
system (Dupont-NEN, Massachusetts, USA) was used to detect the antigen antibody 
complexes. 
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Figure 1: Comparison of amino acid sequence of chicken MyoD to that of human 
and mouse MyoD.  There is about 86% similarity in amino acid sequence between 
the chicken MyoD protein (298 a.a., 33 kDa) and human or mouse MyoD protein 
(320 a.a., 34 kDa). 
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Figure 2: Comparison of amino acid sequence of chicken Myogenin to that of rat and 
mouse Myogenin.  There is about 88% similarity in amino acid sequence between the 
chicken Myogenin protein (227 a.a., 25.8 kDa) and rat or mouse Myogenin protein 
(224 a.a., 25.2 kDa).  
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4.2.5 Immunocytochemistry 
4.2.5.1 Tissue Preparation and Sectioning 
Three muscle samples were excised from the superficial region of the left 
pectoralis muscle of each bird.  Each sample was approximately 0.5 x 0.5 x 1-2 cm.  
The long axis of each sample was parallel to the direction of the muscle fibers.  Each 
sample was then coated with O.C.T. compound (Miles Inc., Indiana, USA) and 
immediately frozen in 2-methylbutane cooled via liquid nitrogen (Sewry and 
Dubowitz 2001).  After that, samples were stored at -80oC. 
 
 Serial cross-sections of 10 μm thickness were cut using a cryostat at -20oC, 
and two serial sections were picked up on each ProbeOn Plus microscopic slide 
(Fisher Scientific Ltd., Ontario, Canada).  The reason for collecting two sections on 
each slide was to increase the possibility of choosing better fields for imaging.  Serial 
slides bearing sections were numbered and stored at -20oC. 
 
4.2.5.2 Immunocytochemistry Protocol 
Slides to be treated with anti-MyoD were removed from the freezer and air 
dried for 15 minutes.  Sections were then treated for 30 minutes with 200 μl of 
blocking solution, which consisted of 5mM EDTA in PBS, 5% goat serum and 1% 
bovine serum albumin.  Blocking solution was drained from each slide onto a paper 
towel.  After that, a cocktail of anti-Pax7 and anti-MyoD primary antibodies diluted 
in blocking solution was applied over the sections on slides using 150 μl per slide.  
The slides were kept overnight in the dark at 4oC.   
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Slides to be treated with anti-Myogenin were removed from the freezer and 
air dried for 15 minutes.  After that, the slides were treated for 10 minutes with 60% 
acetone in Coplin jars (Fisher Scientific Ltd.).  No blocking was used, instead a 
cocktail of anti-Pax7 and anti-Myogenin primary antibodies diluted in the blocking 
solution was applied directly over the sections on slides using 150 μl per slide.  The 
slides were kept overnight in the dark at 4oC. 
 
Anti-MyoD or anti-Myogenin slides were then washed three times in fresh 
PBS solution for five minutes per wash.  A cocktail containing the secondary 
antibodies A-11010 and A11001 was then applied over the sections on each slide for 
45 minutes at room temperature, and followed by two five minutes washes in fresh 
PBS solution.  Hoechst 33258 diluted in PBS was then applied over the sections for 
five minutes, followed by two additional five minutes washes in PBS.  All slides were 
then fixed with 4% formaldehyde in PBS solution for three minutes, and 
subsequently washed twice for five minutes each in fresh PBS solution.  Finally, wet 
slides were mounted with cover slips using Geltol mounting medium (Thermo 
Shandon, Pennsylvania, USA) before being examined by fluorescent microscopy. 
 
4.2.5.4 Image Analysis and Data Collection 
 Five to six different fields of view were captured from slides representing the 
same animal by using a Zeiss Axioskop 20 microscope equipped for epifluorescence 
(Carl Zeiss, Oberkochen, Germany) and a Sony (S70) digital still camera (Sony 
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Electronics Inc., Tokyo, Japan).  Three epifluorescent images, each viewed through a 
different wavelength filter, were acquired from each field.  The resultant images were 
all nuclei in blue, SC nuclei in green and either MyoD+ or Myogenin+ nuclei in red 
(Fig. 3 and 4).  Images were subsequently transferred to a Macintosh G4 computer 
(Apple Computer Inc., California, USA), and the three images for each field of view 
were superimposed using Adobe Photoshop (Adobe System Inc., California, USA).  
The ratios of MyoD+ and Myogenin+ SC nuclei and myonuclei were calculated for at 
least 100 SC nuclei and 200 myonuclei from each bird.  Any Hoechst labeled nucleus 
that did not superimpose the sillohoutte of the fiber was not calculated as a 
myonucleus.  
 
 
4.3 Statistics 
After confirming the homogeneity of variance, data were evaluated by one-
way analysis of variance (ANOVA).  The samples were blocked into six different age 
groups and the ANOVA was applied at 5% level of significance.  When a significant 
difference was found (P < 0.05), Scheffe’s post-hoc analysis test was used for a pair 
wise comparison between different age groups.  Also, independent T-test was applied 
to determine the significance of declination in MyoD and Myogenin expression from 
maturing (117 days post-hatch) to adult (430 days post-hatch) chickens.  All 
statistical tests were performed using SPSS program (standard version 12.0.0,     
SPSS Inc.). 
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Figure 3: Immunofluorescence labeling of a transverse section of a 62 days old 
chicken pectoralis to detect MyoD+ nuclei.  (A) All nuclei appear in blue due to 
labeling by Hoechst.  (B) Satellite cell nuclei appear green after labeling by anti-
Pax7.  (C) MyoD+ nuclei appear red after labeling by anti-MyoD.  Scale bars = 20 
microns. 
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Figure 4: Immunofluorescence labeling of a transverse section of a 62 days old 
chicken pectoralis to detect Myogenin+ nuclei.  (A) All nuclei appear in blue due to 
labeling by Hoechst.  (B) Satellite cell nuclei appear green after labeling by anti-
Pax7.  (C) Myogenin+ nuclei appear red after labeling by anti-Myogenin.            
Scale bars = 20 microns. 
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4.4 Results 
4.4.1 Specificity of MyoD and Myogenin Antibodies 
 The specificity of anti-MyoD and anti-Myogenin antibodies was confirmed by 
Western blot analyses.  Anti-MyoD immunoreactivity was shown as a single band at 
around 38 kDa (Fig. 5A; Yamamoto and Kuroiwa 2003), while anti-Myogenin 
immunoreactivity was detected as a single band that appeared at about 36 kDa (Fig. 
5B; Fujisawa-Sehara et al. 1990).  Also, the immunoreactivity of these antibodies 
with L8 cell extract confirmed the specificity of these antibodies.  These findings 
indicate that the anti-MyoD and anti-Myogenin polyclonal antibodies used in this 
study recognize chicken proteins consistent with that predicted for MyoD and 
Myogenin respectively. 
 
4.4.2 Expression Pattern of MyoD  
 As illustrated in Figure 6, the percentage of MyoD+ SC nuclei increased 
significantly (P < 0.001) with age.  While the percentage of SCs expressing MyoD 
was 16.67% at age 9 days post-hatch, this value increased to reach 91.67% around 
maturation at age 117 days.  However, this percentage then declined significantly    
(P < 0.001) to 75.69% at 430 days of age. 
 
 In myonuclei, the MyoD+ ratio also increased significantly (P < 0.001) during 
maturation.  The percentage of MyoD+ myonuclei was 78.50% at age 9 days post-
hatch and increased up to 95.17% at 117 days post-hatch.  Similar to MyoD labeling 
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of SCs, this value declined significantly (P < 0.005) after maturation to reach 72.50% 
at age 430 days. 
 
4.4.3 Expression Pattern of Myogenin 
 The percentage of Myogenin+ SCs increased significantly (P < 0.01) at early 
stages of development from 36.04% at age 9 days to 44.86% at age 30 days (Fig. 7).  
After that, the proportion was almost constant until maturation and never rose above 
47.67%.  On the other hand, the percentage of Myogenin+ myonuclei increased 
significantly (P < 0.001) during development from 44.85% at age 9 days post-hatch 
to 75.28% at 117 days post-hatch.  After maturation, the percentages of both 
Myogenin+ SC nuclei and myonuclei declined significantly to 25.06% (P < 0.005) 
and 20.83% (P < 0.001), respectively, at 430 days post-hatch (Fig. 7).  
 
 
 
 
 
 
 
 
 
 
 
 68
 
 
 
 
Figure 5: Western blot analyses for anti-MyoD and anti-Myogenin antibodies.  (A) A 
Western blot probed with anti-MyoD antibody against chicken pectoralis extracts 
from age 9 and 49 days post-hatch and L8 cultured rat myoblast extract used as a 
positive control.  (B) A Western blot probed with anti-Myogenin antibody against the 
same samples used in (A).  In both analyses, there was only a single band detected on 
the membrane, suggesting the specificity of these antibodies for their corresponding 
proteins.  See appendices D and E for whole membrane photos of, respectively, 
MyoD and Myogenin Western blot analyses. 
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Figure 6: Expression of MyoD protein within satellite cell nuclei (SCN) and 
myonuclei (MN).  The percentages of both MyoD+ satellite cell nuclei and MyoD+ 
myonuclei increase significantly (P < 0.001) during development and reach peak 
values near maturation at age 117 days post-hatch, where more than 90% of these 
nuclei are MyoD+.  However, this percentage declines after the birds are mature.  
Columns with different letters are significantly different (Scheffe’s, P < 0.05).  Small 
letters are used for SCN (green columns) and large letters are used for MN (blue 
columns). 
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Figure 7: Expression of Myogenin protein within satellite cell nuclei (SCN) and 
myonuclei (MN).  The percentage of Myogenin+ satellite cell nuclei increases 
significantly (P < 0.05) from age 9 days to age 30 days post-hatch.  After that, this 
percentage appears to remain steady during the post-hatch developmental period.  It 
then declines as the birds mature.  In myonuclei, Myogenin expression increases 
significantly (P < 0.001) with development until maturation after which it declines.  
Columns with different letters are significantly different (Scheffe’s, P < 0.05).  Small 
letters are used for SCN (green columns) and large letters are used for MN (blue 
columns). 
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4.5 Discussion 
This study uses immunocytochemical techniques to analyze the expression 
patterns of MyoD and Myogenin during post-hatch development of the chicken.  
Antibodies developed against MyoD and Myogenin proteins are used to detect 
MyoD+ and Myogenin+ nuclei, after the specificity of these antibodies is 
demonstrated by Western analyses.  The percentages of MyoD+ and Myogenin+ 
myonuclei are significantly increased during maturation.  On the other hand, while 
the percentage of MyoD+ SC nuclei increases significantly with maturation, the 
percentage of Myogenin+ SC nuclei has increased only at early stages of 
development and then remains nearly constant.  At all ages more myonuclei express 
MyoD than Myogenin.  In SCs, at early ages of development, fewer SCs express 
MyoD than Myogenin.  However, as the number of SCs expressing MyoD increases 
significantly with age, it surpasses the number of SCs that express Myogenin.  This 
difference in expression between MyoD and Myogenin within SC nuclei suggests 
they may be required at different activated stages of SCs and perhaps play different 
roles during SC activation.   
 
Previous in vitro studies established that the expression of MyoD in cultured 
myoblasts inhibits their proliferation and enhances myotube formation (Sorrentino et 
al. 1990; Crescenzi et al. 1990; Montarras et al. 1991; Wilson et al. 2003).  On the 
other hand, lack of MyoD expression in cultured myoblasts enhances proliferation, 
and impairs their capacity to differentiate (Montarras et al. 1989; Sabourin et al. 
1999; Cornelison et al. 2000; Schuierer et al. 2005).  Other in vitro studies have 
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shown that MyoD expression could induce terminal cell cycle arrest during myoblast 
differentiation by increasing the expression of cyclin dependant kinase inhibitor 
protein p21 (Halevy et al. 1995; Guo et al. 1995).  Collectively, these previous works 
demonstrate that MyoD is required for cessation of myoblast proliferation and 
transition to differentiation. Myogenin expression was found to always accompany 
the terminal differentiation stage of cultured myoblasts (Emerson 1990; Montarras et 
al. 1990; Smith et al. 1994; Yablonka-Reuveni and Paterson 2001).  This suggests 
that Myogenin expression can demarcate the end stage of differentiation within 
cultured myoblasts and transition towards myotube formation.   
 
These previous in vitro studies lead to the conclusion that each of these 
factors, along with Pax7, can demarcate a specific stage of development within SCs 
until their differentiation to myonuclei (Fig. 7).  The expression of Pax7 can specify 
SCs in all their different stages; quiescent and active (Seale et al. 2000; Olguin and 
Olwin 2004; Halevy et al. 2004; Relaix et al. 2005; Kuang et al. 2006).  MyoD starts 
to be expressed at the end stage of SC (Pax7+/MyoD+) proliferation to enhance 
differentiation and continues after their maturation to myonuclei (Pax7-/MyoD+).  
The expression of Myogenin demarcates the end stage of differentiation 
(Pax7+/Myogenin+) and continues after myotube formation (Pax7-/Myogenin+).  
This is comparable to what Zammit et al. (2006a) have suggested. 
 
  The increased number of MyoD+ SCs detected in this study during 
maturation means that more of these active cells withdraw from the cell cycle and 
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either move toward differentiation and fusion to muscle fibers, or return to quiescence 
as the birds grow.  The number of Myogenin+ SCs increased significantly (to about 
45%) until age 30 days where it remained until maturation.  This leads to the 
assumption that the rate of differentiation increases significantly at very early stages 
of postnatal development and then remains constant during maturation.  These data 
combined indicate that, as increasing numbers of SCs stop proliferation (MyoD+) 
during post-hatch growth, a constant percentage of these cells will differentiate to 
myonuclei (Myogenin+).  Presumably, the remaining SCs will move toward G0 phase 
to become quiescent later on and lose the expression of MyoD.  After maturation, 
both rates of proliferation and differentiation decline as SCs become more quiescent. 
 
Until now, few in vivo studies have investigated the expression and functions 
of MyoD and Myogenin within skeletal muscle.  It has been demonstrated in studies 
of rodent muscles that MyoD and Myogenin are expressed in active SC nuclei and 
recently formed myonuclei (Grounds et al. 1992; Fuchtbauer and Westphal 1992; 
Ishido et al. 2004b).  Also, Ishido et al. (2004a) have reported the expression of 
MyoD and Myogenin within nuclei located in the interstitial spaces between muscle 
fibers.  This study is the first to report the patterns of MyoD and Myogenin 
expression throughout postnatal development until maturation. Numerous 
unanswered questions remain, however, regarding the exact functions of MyoD and 
Myogenin within skeletal muscle during postnatal development.  Do these factors 
interact with each other?  Do they play dual roles during the activation of SCs?  It is 
clear that MyoD and Myogenin, along with other myogenic regulators, do not 
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function alone but rather they participate in a regulatory network that involves a 
variety of positive and negative factors.  Further investigations are still required in 
order to unveil the complete in vivo picture regarding MyoD and Myogenin functions 
during postnatal development.   
 
In summary, this study reveals that the percentages of MyoD+ and 
Myogenin+ nuclei are relatively high within growing chicken skeletal muscle.  The 
number of SCs that express MyoD increases significantly during post-hatch 
development, while Myogenin expression is limited to about half of SC population 
during this period.  It is speculated that MyoD is expressed in late proliferating and in 
differentiated SCs.  This implies that MyoD can distinguish active from quiescent 
SCs.  Myogenin is thought to be expressed at the end of the differentiation stage, 
where it is positively correlated with the rate of SC differentiation within skeletal 
muscle. 
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Quiescent SC     ⇒     Proliferative     ⇒     Differentiated     ⇒     Myonucleus 
[---------------------------- Pax7 -----------------------------------] 
     [--------------------    MyoD    ----------------------?        
                                                               [-------- Myogenin --------? 
 
 
 
Figure 8: The patterns of expression for Pax7, MyoD and Myogenin factors by 
satellite cell (SC) nuclei during different developmental stages.  Pax7 is expressed by 
SCs in their quiescent and active states.  MyoD expression demarcates the end of 
proliferation stage and transition towards differentiation.  Myogenin expression 
begins at the terminal stage of SC differentiation. 
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5.0 CHAPTER 
 
 
FREQUENCY AND CONCENTRATION OF SATELLITE CELLS 
IN MEAT PRODUCING CHICKENS AS A NATURAL MODEL 
OF MUSCLE HYPERTROPHY 
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5.1 Introduction 
Skeletal muscle is composed of long, multinucleated cells known as muscle 
fibers (Trotter 1991; Allen et al. 1995; Gartner and Hiatt 2001).  Postnatal growth of 
skeletal muscle occurs either through hypertrophy, an increase in fiber size or, to a 
lesser extent, through hyperplasia, an increase in fiber number (Goldspink 1972; 
Gollnick et al. 1981; 1983; Alway et al. 1990).  These two growth mechanisms 
depend mainly on the contribution of a specific population of myogenic progenitors 
termed satellite cells (SCs; Asakura et al. 2002; Mckinnell et al. 2005). 
 
SCs are mononucleated myogenic stem cells situated between the basal 
lamina and plasmalemma of the muscle fiber and are responsible for postnatal muscle 
growth and repair (Mauro 1961; Morgan and Partridge 2003; Mckinnell et al. 2005).  
During growth, active SCs proliferate then differentiate by fusing to a preexisting 
muscle fiber or by fusing together to form a new fiber (Hawke and Garry 2001; 
Morgan and Partridge 2003; Jarvinen et al. 2005).  Eventually SC nuclei become new 
myonuclei (Moss and Leblond 1971; Hawke and Garry 2001; Morgan and Partridge 
2003).  A small portion of SCs, however, do not differentiate but instead revert to 
quiescence to maintain a self-renewal pool after maturation (Morgan and Partridge 
2003; Wozniak et al. 2004).  
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SCs can be identified by their characteristic position beneath the muscle fiber 
basal lamina or by their ability to express specific protein markers such as the paired 
box transcription factor seven (Pax7; Hawke and Garry 2001; Morgan and Partridge 
2003; Wozniak et al. 2004).  Pax7 is specifically expressed by SCs in all their 
different stages: quiescent, active, proliferative and differentiated (Seale 2000; Olguin 
and Olwin 2004; Kuang et al. 2006).  An earlier study has confirmed the specific 
expression of Pax7 by all SCs in the pectoralis muscle of chickens (Halevy et al. 
2004). 
 
Previous studies have shown that an increase in myonuclear number is 
necessary to increase the volume of muscle fibers during postnatal growth (Cheek et 
al. 1971; Darr and Schultz 1989; Edgerton and Roy 1991).  The increased myonuclear 
number is needed to maintain a constant volume of cytoplasm per myonucleus within 
the growing fibers (Moss 1968; Allen et al. 1995).  The myonuclear domain has been 
defined as the average volume of cytoplasm associated with a single myonucleus 
(Rosser et al. 2002).  On the other hand, it has been found that actively growing 
muscle fibers have more SCs (Moss and Leblond 1971; Schultz et al. 1978).  For 
example, the frequency of SCs declines from about 20% in the growing chicken’s 
pectoralis to less than 5% at maturation (Halevy et al. 2004).  Since SCs are the main 
source of new myonuclei, it is surmised that a higher number of SCs is required to 
meet the greater demand for myonuclei in growing muscle fibers.  
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This study examines the distribution of SCs and myonuclei in growing meat 
producing chickens, as a natural model of muscle hypertrophy.  This model was 
chosen because there are some suggestions that experimental models do not represent 
natural processes (Rosser and George 1987; Mokhtarian et al. 1999).  This research 
provides a chance to compare the frequency and concentration of SCs in the natural 
model of hypertrophy with that of experimental models studied before.  Another 
important factor for using these chickens is that in the meat production industry very 
little is known about these birds at the cellular level.  Data obtained by this study may 
be applied to enhance meat production. 
 
The research hypothesis is that there are a greater frequency and concentration 
of SCs and greater number of myonuclei in hypertrophied muscle of a natural model.  
These naturally hypertrophied muscles are obtained from the M and Y lines of 
growing Ross Breeder meat producing chickens, while the control ones are obtained 
from the control C line.  Applying immunocytochemical techniques, including 
antibody against Pax7 to identify SC nuclei, it was possible to measure the 
distribution of SCs and myonuclei among these different chicken lines.  The 
frequency and concentration of SCs were significantly (P < 0.001) higher in the meat 
producing lines (M and Y) than in the control (C) line.  Also, significantly (P < 
0.001) greater numbers of SCs and myonuclei per unit length of the fiber were found 
in the meat producing lines. 
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5.2 Materials and Methods 
5.2.1 Experimental Model 
 The chicken pectoralis muscle of Ross Breeder meat producing chickens 
(Ross Breeder Ltd, Newbridge, Scotland) was the experimental model used in this 
study.  The study pool was composed of three distinct lines; the M and Y lines, which 
are the meat producing birds, and the C-line, from which M and Y lines were 
selected, acting as the control line.  While fast growing M and Y line birds need only 
six weeks (42 days) to reach market weight, the slow growing C line needs 12 weeks.  
Following the Canadian Council on Animal Care Guidelines, five birds of each line 
were sacrificed by cervical dislocation at age 42 days.   
 
 
5.2.2 Tissue Preparation and Sectioning 
The right pectoralis muscle was cut from each bird and weighed.  Several 
muscle samples were excised from the superficial region of the proximal two thirds of 
each muscle.  Each muscle sample was approximately 0.5 X 0.5 X 1.0 – 2.0 cm with 
its long axis parallel to the direction of the muscle fibers.  Each sample was then 
coated with O.C.T. compound (Miles Inc., Indiana, USA) and immediately frozen in 
2-methylbutane cooled via liquid nitrogen (Sewry and Dubowitz 2001).  Samples 
were subsequently stored at -80oC. 
 
 Serial cross-sections of 10 μm thickness were cut using a cryostat at -20oC.  
Two serial sections were picked up on each ProbeOn Plus microscopic slide (Fisher 
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Scientific Ltd., Ontario, Canada).  The reasons for collecting two sections on each 
slide were to increase the opportunity of choosing better fields for imaging.  Serial 
slides bearing sections were then numbered and stored at -20oC. 
 
5.2.3 Antibodies and Nuclear Labeling Agent 
 The previously characterized primary antibodies used for immunostaining 
were anti-Pax7 and anti-laminin.  Anti-Pax7 (Developmental Studies Hybridoma 
Bank, Iowa, USA; Berggren et al. 2001), a mouse monoclonal antibody developed 
against chicken Pax7, was used at a dilution of 1:100 to detect SC nuclei.  Anti-
laminin (L9393, Sigma Chemical Co., Missouri, USA; Tisay and Key 1999), a rabbit 
polyclonal antibody raised against the glycoprotein laminin of mice origin, was used 
at 1:200 dilution to detect the basal laminae of skeletal muscle fibers.  
 
Fluorescein isothiocyanate-conjugated anti-mouse and tetramethyl rhodamine 
anti-rabbit secondary antibodies (A-11010 and A-11001, Molecular Probes, Oregon, 
USA) were used, respectively, to label anti-Pax7 in green and anti-laminin in red 
when viewed with epifluorescent microscopy.  Each of these secondary antibodies 
was prepared at a dilution of 1:200 in phosphate-buffered saline (PBS; 0.02 M 
sodium phosphate buffer, 0.15 M sodium chloride, pH 7.2).  Hoechst 33258 
(Bisbenzimide, 10 mg/ml stock concentration, Sigma Chemical Co., Missouri, USA) 
was applied at a dilution of 1:1,500,000 in PBS to label the DNA in all nuclei blue 
under epifluorescent microscopy.    
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5.2.4 Immunocytochemical Technique  
Slides were removed from the freezer and air dried for 15 minutes.  Sections 
were then treated for 30 minutes with 200 μl of blocking solution, consisting of 5mM 
EDTA in PBS, 5% goat serum and 1% bovine serum albumin.  Blocking solution was 
drained from each slide onto a paper towel.  Anti-Pax7 and anti-Laminin primary 
antibodies diluted in blocking solution were then applied together over the muscle 
sections on slides using 150 μl per slide.  The slides were kept in the dark at 4oC 
overnight.  
 
After that, slides were washed three times in fresh PBS solution for five 
minutes per wash.  A cocktail containing the secondary antibodies A-11010 and 
A11001 was then applied over the sections on each slide for 40 minutes at room 
temperature, and followed by two five minutes washes in fresh PBS solution.  
Hoechst 33258 was applied over the sections for five minutes, followed by two 
additional five minutes washes in PBS.  All slides were then fixed with 4% 
formaldehyde in PBS solution for three minutes, and then washed twice for five 
minutes each in fresh PBS solution.  Finally, wet slides were mounted with cover 
slips using Geltol mounting medium (Thermo Shandon, Pennsylvania, USA) and left 
to harden for 20 minutes before being examined under epifluorescent microscopy. 
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5.2.5 Image Analysis and Data Collection 
 Four to six different fields of view were captured from each 
immunofluorescent slide using a Zeiss Axioskop 20 microscope equipped for 
epifluorescence (Carl Zeiss, Oberkochen, Germany) and a Sony (S70) digital still 
camera (Sony Elctronics, California, USA).  Three epifluorescent images were taken 
for each field with a different wavelength filter.  The resultant images were all nuclei 
in blue, SC nuclei in green and the basal lamina in red (Fig. 1).  Images were 
subsequently transferred to a Macintosh G4 computer (Apple Macintosh, California, 
USA), and the three images of each field of view were then superimposed using 
Adobe Photoshop (Adobe System Inc., California, USA).   
 
The ellipse minor axis of 200 contiguous fiber profiles from each animal was 
measured to assess fiber size.  It is defined as the maximum diameter across the lesser 
aspect of a fiber (Rosser et al. 2000).  The basal lamina images were used to measure 
the ellipse minor axis of individual fibers. The images format was changed to TIFF 
format, and Scion imaging program (developed by US National Institute of Health; 
Image J is the current version that is available on the internet at 
http://rsb.info.nih.gov/ij) was then used to set the images to gray scale to measure the 
ellipse minor axis.  
 
The numbers of satellite cell nuclei (SCN) and myonuclei (MN) were counted 
for each of the 200 fibers.  After that, the frequency of satellite cells was calculated 
for each bird using the following formula, frequency = (SCN / SCN+MN) X 100%.  
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The mean values for SC frequency per group were obtained from five birds in each 
group. 
 
The number of SCs and number of myonuclei per unit length of fiber were 
calculated for each bird applying the formula used by Castillo de Maruenda and 
Franzini-Armstrong (1978).  This formula is N= A/(Ln + M), where N is the number 
of cells per unit length of fiber, A is the mean number of nuclei per fiber profile, Ln is 
the average length of the nucleus and M is the thickness of tissue section.  The mean 
surface area of the sarcolemma per fiber unit length was also calculated using the 
formula S= πEU, where S is the surface area of the plasmalemma per unit length of 
fiber, E is the ellipse minor axis and U is the unit length of the fiber (1 mm).  The area 
of muscle fiber sarcolemma for each SC was determined by dividing the mean 
surface area measurement by the mean number of SCs per unit length in each bird.  
The myonuclear domain size was calculated for each bird by dividing the mean 
volume of cytoplasm per unit length of fiber by the mean number of myonuclei in 
that unit length.  The volume of cytoplasm per unit length of fiber (V) was computed 
using the formula V= π(E/2)2U.  The abbreviations are the same as defined 
previously. 
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Figure 1: Immunofluorescent identification of satellite cell nuclei in transverse 
sections from pectoralis muscles of the C, M and Y lines of Ross Breeder chickens at 
age 42 days post-hatch.  A and B represent a section taken from the pectoralis muscle 
of a control C line bird, while C and D are taken from the pectoralis of an M-line 
bird, and  E and F from the pectoralis muscle of a Y-line bird.  A, C and E show all 
nuclei labeled in blue by Hoechst and basal laminae in red labeled by anti-laminin.  
B, D and F reveal satellite cell nuclei labeled in green by anti-Pax7 and basal laminae 
in red labeled by anti-laminin.  Scale bars = 30 µm.  
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5.3 Statistics 
 After determining the homogeneity of variance, data were evaluated by the 
one-way analysis of variance (ANOVA) at 5% level of significance.  The samples 
were blocked into three different groups and ANOVA was applied.  If a significant 
difference was found (P < 0.05), Scheffe’s post-hoc analysis test was applied to 
examine the statistical differences between groups.  All statistical analyses were 
performed using SPSS program (standard version 12.0.0, SPSS Inc.). 
 
 
5.4 Results 
5.4.1 Size of Fibers’ Cross Sectional Profiles 
 The ellipse minor axis was the measurement used to quantify the size of fibers 
among the three different bird lines.  The mean size of fiber profile was significantly 
(P < 0.001) larger in both the M and Y line birds than in the birds of the C line (Fig. 
2).  The mean ellipse minor axis ± standard error (SE) in C-line birds was 31.73 ± 
1.67 µm, while it was 51.76 ± 1.31 µm in birds of M line and 54.17 ± 1.44 µm in Y 
line birds. 
 
5.4.2 Frequency of SCs among M, Y and C lines 
 As evident in Figure 3, the frequency of SCs was significantly (P < 0.001) 
higher in birds of both the M and Y lines compared to those of the control C line.  On 
the other hand, there was no significant (P = 0.33) difference in SC frequency 
between birds of the M and Y lines.  The mean frequency in C line birds ± SE was 
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10.85 ± 0.36 %.  This value increased to 14.10 ± 0.32 % in the M line birds, and to 
13.57 ± 0.08 % in the Y line birds. 
 
5.4.3 Number of SCs per Unit Length of Fiber 
The number of SCs along a mm of fiber was significantly (P < 0.001) higher 
in the M and Y line Birds than in the C line birds.  In the control C line birds, the 
mean number of SCs per mm segment of the fiber ± SE was 11.50 ± 0.32.  This 
number was 27.65 ± 1.38 in M line birds and 24.60 ± 1.03 in Y line birds. 
 
5.4.4 Surface Area of Sarcolemma per SC 
 The surface area of muscle fiber sarcolemma was calculated for each of the 
three bird lines.  There was significantly (P < 0.001) less surface area of sarcolemma 
per SC in the M and Y lines than in the C line birds (Fig. 4).  The mean surface area 
per SC ± SE in the C line group was 8,667.40 ± 428.99 µm2.  This value was 
5,841.37 ± 198.46 in M line group and 6,937.35 ± 189.31 in Y line group.  These 
results indicate that there is a greater concentration of SCs in the M and Y line birds 
than in the control C line birds. 
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5.4.5 Number of Myonuclei per Unit Length of Fiber 
 There was significantly (P < 0.001) more myonuclei per mm of fiber in the M 
and Y lines than in the C line.  The mean myonuclear number per mm of fiber ± SE 
in the C line was 95.00 ± 4.56.  This number was 168.00 ± 4.64 in M line and 157.00 
± 6.24 in Y line. 
 
5.4.6 Myonuclear Domain Size  
The size of myonuclear domain (volume of cytoplasm per myonucleus) was 
measured for each line.  Surprisingly, the myonuclear domain was significantly              
(P < 0.001) larger in both the M and Y line birds than in those of the C line (Fig. 5).  
The mean myonuclear domain size in the C line group ± SE was approximately 
8,334.17 ± 551.03 µm3.  This mean size value was 12,532.52 ± 417.07 µm3 in M line 
group and 14,716.01 ± 575.86 µm3 in Y line group. 
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Figure 2: Size of fiber cross sectional profiles in the pectoralis muscle of the C, M 
and Y lines of Ross Breeder chickens at age 42 days post-hatch.  The ellipse minor 
axis was measured for the pectoralis muscle fibers from five birds in each line.  Each 
column represents the mean ellipse minor axis in micrometers (μm) ± standard error 
(SE).  The minor axis is found to be significantly (P < 0.001) larger in the selected 
meat producing M and Y lines, which represent the naturally hypertrophied model, 
than in the control C line.  Columns with different letters are significantly different 
(Scheffe’s, P < 0.05). 
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Figure 3: Satellite cell (SC) frequency in the pectoralis muscle of the C, M and Y 
lines of Ross Breeder chickens at age 42 days post-hatch.  The frequency of SCs, (SC 
nuclei/SC nuclei + myonuclei) x 100%, was obtained from five birds in each line.  
Numbers of SC nuclei and myonuclei were counted separately in 200 contiguous 
fibers for each muscle sample.  Each column represents mean SC frequency ± 
standard error (SE).  The frequency is significantly (P < 0.001) greater in both 
hypertrophied fibers of the M and Y lines than those in the control C line.  Columns 
with different letters are significantly different (Scheffe’s, P < 0.05).  
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Figure 4: Surface area of sarcolemma per satellite cell (SC) in the pectoralis muscle 
of the C, M and Y lines of Ross Breeder chickens at age 42 days post-hatch.  The area 
of sarcolemma (μm2) for each SC was measured in five birds from each line.  Each 
column represents the mean area of sarcolemma per SC ± standard error (SE).  There 
is significantly (P < 0.001) less area per SC in the M and Y lines than in the C line.  
This means that SCs are located closer together in M and Y lines than in the C line 
birds.  Columns with different letters are significantly different (Scheffe’s, P < 0.05). 
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Figure 5: Size of myonuclear domain in pectoralis muscle of the C, M, and Y lines of 
Ross Breeder chickens at age 42 days post-hatch.  The myonuclear domain size was 
measured in the pectoralis muscle of five birds from each line.  Each symbol 
represents the mean myonuclear domain size (μm3) ± standard error (SE).  The 
domain size is significantly (P < 0.001) larger in M and Y lines than in the C line 
birds.  Columns with different letters are significantly different (Scheffe’s, P < 0.05). 
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5.5 Discussion  
This study investigates the distribution of SCs and myonuclei in the growing 
hypertrophied fibers of Ross Breeder’s strain of meat producing chickens.  These 
birds offer a natural model of muscle fiber hypertrophy.  Various methods have been 
reported by many researchers to induce muscle fiber hypertrophy in both humans and 
laboratory animals.  A well known and established method is exercise-induced 
muscle hypertrophy (Goldspink and Howells 1974; Gonyea 1980; Kadi and Thornell 
2000).  In this method, the hypertrophy is induced by prolonged exercise regimens 
under normal physiological conditions.  Another method known as compensatory 
hypertrophy, has also been used to enhance muscle growth (Gollnick et al. 1981; 
Salleo et al. 1983; Timson et al. 1985).  Three procedures inducing compensatory 
hypertrophy have been reported: tenotomy (severing the tendon of the synergistic 
muscle), ablation (complete or partial removal of synergistic muscle) and denervation 
(cutting of the synergistic muscle motor neuron).  In birds, a common method used to 
produce hypertrophy in wing muscles is the stretch-induced hypertrophy (Holly et al. 
1980; Alway et al. 1989a; Antonio and Gonyea 1993).  In this method a weight is 
hung from the tip of the bird’s wing for a sufficient period of time.  However, the 
hypertrophy resulting from the stretch-induced model seems to be associated with 
inflammation and edema in the muscle and therefore it cannot be compared with 
physiological muscle hypertrophy.  The present study is unique in that it is the first to 
measure SC distribution in a natural model of enlarged fibers. 
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This study demonstrates that the hypertrophied fibers of growing muscles 
have a greater frequency, number and concentration of SCs.  Also, it shows a greater 
number of myonuclei in the hypertrophied fibers than in the normal control ones.  
Growing fibers require a higher rate of protein synthesis and this is achieved through 
supplying more myonuclei (Edgerton and Roy 1991; Allen et al. 1999; Ohira et al. 
2001).  Also, myonuclei arise from SCs (Seale and Rudnicki 2000; Hawke and Garry 
2001).  Thus, the greater numbers of SCs and myonuclei observed in the growing 
hypertrophied fibers is presumably correlated with the high demand for protein 
synthesis in these fibers. 
 
Previous studies have reported a positive correlation between muscle 
hypertrophy, and the numbers of SCs and myonuclei.  Kadi and Thornell (2000) 
observed an increase in the numbers of SCs and myonuclei within human trapezius 
muscle after a strength training program.  Testosterone-induced muscle hypertrophy 
was also associated with an increase in the number of SCs and a proportional increase 
in the number of myonuclei (Sinha-Hikim et al. 2003).  Winchester et al. (1991) 
demonstrated that SCs are induced to enter the cell cycle and proliferate in stretch-
enlarged anterior latissimus dorsi muscle of the adult quail.  Similar to these earlier 
studies conducted on experimental models of hypertrophy, the natural model of 
hypertrophy studied here shows the same association between enlarged muscle fibers 
and the increased numbers of SCs and myonuclei.  
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Even though the number of myonuclei per mm of fiber was greater in the M 
and Y lines, the size of myonuclear domain was much larger in these two lines than 
in the control line.  Although some previous studies suggested that smaller domain 
size, where myonuclei are closer together, indicates a high rate of protein synthesis 
and growth (Knizetova et al. 1972; Edgerton and Roy 1991), other studies showed 
that atrophy of hindlimb muscle fibers was also associated with smaller myonuclear 
domain size (Allen et al. 1996, 1997; Kasper and Xun 1996a, 1996b; Verheul et al. 
2004).  Still, it has not been shown that larger domains have a slower rate of growth 
or less active myonuclei.  Chen et al. (2002) mentioned that enhanced transcriptional 
and translational activities of myonuclei lead to expansion of the myonuclear domain 
size.  Therefore, it can be extrapolated that the size of myonuclear domain cannot 
always be used as an indicator of growth activity, and that myonuclei in the M and Y 
line birds can be actively involved in protein synthesis.  An explanation for this might 
be that the rate of fiber growth is much faster than the rate of myonuclei formation 
from SCs.  Kadi and Thornell (2000) reported an increased myonuclear number 
within hypertrophied fibers of human trapezius muscle, and suggested this increase is 
to maintain an optimal cytoplasm-to-myonuclear ratio.  However, they did not 
attempt to measure the size of myonuclear domain in their study.  In 2005, the same 
researchers reported a larger myonuclear domain size within hypertrophied fibers of 
human vastus lateralis muscle (Eriksson et al. 2005). 
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 The difference in growth rate between meat and control birds can be attributed 
to genetic and nutritional factors (Grossmann et al. 2004).  Meat birds were found to 
exhibit a higher level of growth hormone receptor mRNA transcripts within skeletal 
muscle tissue compared to control birds (Zhao et al. 1998).  Also, significantly higher 
plasma IGF-1 concentrations were detected in hypertrophied meat producing 
chickens compared to normal chickens (Zhao et al. 1996).  Meat producing chickens 
usually receive a high protein diet.  Feeding normal chickens with this high protein 
diet resulted in 35% increase of body weight at age 42 days post-hatch, when 
compared to chickens that received the normal diet (Grossmann et al. 2004). 
 
In conclusion, the results of this study are consistent with that of earlier 
studies conducted on experimental models of hypertrophy.  This suggests that these 
experimental models are valid and resemble the natural process of hypertrophy.  The 
frequency and concentration of SCs as well as the number of myonuclei are found to 
be greater in hypertrophied fibers of meat producing chickens compared to normal 
fibers of the control birds.  Concomitantly, there has been a larger myonuclear 
domain size in the M and Y hypertrophied fibers than in the control C line fibers.  
This may be an indication of a high myonuclear activity within M and Y line fibers. 
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6.0 CHAPTER 
 
 
THE EFFECTS OF NANDROLONE DECANOATE ON THE 
DISTRIBUTION OF SATELLITE CELLS AND THE 
MORPHOLOGY OF SKELETAL MUSCLE FIBERS 
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6.1 Introduction 
 Vertebrate skeletal muscle fibers are elongated multinucleated cells (Trotter 
1991; Allen et al. 1995; Gartner and Hiatt 2001).  These fibers are unusual in that 
they do not undergo division during postnatal life.  Instead, growth of skeletal muscle 
occurs by increase in the size of the fibers or, to a very limited extent, by formation of 
new fibers (Goldspink 1972; Alway et al. 1990).  These two growth mechanisms, 
known as hypertrophy and hyperplasia respectively, depend mainly on the 
contribution of a specific population of myogenic precursors known as satellite cells 
(SCs). 
  
 SCs are mononucleated myogenic stem cells that reside between the basal 
lamina and plasmalemma of the muscle fiber (Mauro 1961; Mckinnell et al. 2005; 
Zammit et al. 2006a).  They contribute to muscle growth and repair by fusing and 
adding new myonuclei to the fiber (Moss and Leblond 1971; Hawke and Garry 
2001).  Under normal conditions, SCs are usually quiescent in their characteristic 
location beneath the basal lamina.  When there is a need for growth or repair in the 
muscle, SCs become active and start to proliferate.  After that, the daughter cells fuse 
to the fiber and differentiate to become myonuclei.  In a less common scenario, SCs 
can fuse together to form new myofibers (Hawke and Garry 2001; Dhawan and 
Rando 2005; Zammit et al. 2006a).  The remaining cells revert to a quiescent state to 
maintain a reservoir of these cells (Wozniak et al 2005; Dhawan and Rando 2005; 
Zammit et al. 2006a). 
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Identification of SCs is made based upon either their characteristic location 
beneath the basal lamina, or by detecting specific proteins expressed only by SCs such 
as the paired box transcription factor 7 (Pax7), M-Cadherin or CD 34 (Hawke and 
Garry 2001; Morgan and Partridge 2003).  The advantage of Pax7 is that it is 
expressed by SCs during all their stages: quiescent, proliferative and differentiated 
(Seale et al. 2000; Olguin and Olwin 2004; Relaix et al. 2005; Kuang et al. 2006).  In 
the previous study in chapter 3.0 the specific expression of Pax7 by all SCs in the 
pectoralis muscle of post-hatch chicken was confirmed.  
 
 Anabolic androgenic steroids (AAS) are synthetic derivatives of the 
endogenous primarily male steroid hormone, testosterone.  The anabolic effect of 
AAS helps the body retain dietary protein, thereby aiding growth of muscles, bone 
and skin.  The androgenic properties of AAS include the activation of male 
reproductive system and development of secondary sexual characteristics, such as 
hair distribution and musculoskeletal configuration (Ciccero and O’Connor 1990; 
Mottram and George 2000; Kuhn 2002).  AAS were originally developed for 
treatment of hypogonadal dysfunction, commencement of delayed puberty in men 
and for growth promotion (Basaria et al. 2001).  However, due to their anabolic 
effects, AAS have become vastly popular among athletes of different kinds of sports.  
It is already established that AAS increase skeletal muscle mass, strength and 
endurance (Lukas 1993; Bhasin et al. 1996; Wouter et al. 2004).  Yet, the exact 
mechanisms by which they do so are poorly understood.  Sinha-Hikim et al. (2004) 
have confirmed the localization of androgenic receptors in SC nuclei.  Activation of 
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SCs by AAS is thought to be one of the mechanisms by which these drugs can lead to 
the hypertrophy of skeletal muscles. 
 
 The steroid Nandrolone Decanoate is one of the most popular and commonly 
used anabolic steroids (Perry et al. 1990; Verroken 2001).  Its popularity is likely due 
to the fact that it exhibits significant anabolic effects with minimal androgenic side 
effects.  This makes Nandrolone a very well tolerated drug that is useful for helping 
in the treatment of a wide variety of clinical conditions, such as chronic obstructive 
pulmonary diseases (Creutzberg et al. 2003), osteoporosis and osteopenia (Flicker et 
al. 1997; Li et al. 2000), joint pain (Leardini et al. 1981; Bird et al. 1987) and also for 
HIV.  In HIV patients, Nandrolone has been shown to be effective at safely 
increasing the lean bodyweight of these patients (Cuerda et al. 2005; Gold et al. 
2006).  A recommended intramuscular therapeutic dose of Nandrolone is suggested to 
be 0.4 mg/kg/day in humans (Tamaki et al. 2003).  However, this dose can vary 
widely based on the type of the medical condition and on its severity.   
 
Nandrolone is also the most widespread anabolic steroid used by athletes and 
especially bodybuilders for muscle buildup (Wouter et al. 2004).  It is also known as 
the anabolic steroid Deca Durabolin.  Its anabolic activity on muscle tissue is thought 
to be superior to that of testosterone (Shahidi 2001).  However, it appears less 
effective than testosterone in producing the androgenic effects on other tissues such 
as; skin and nervous tissue.  Nandrolone has a half-life in the muscle of 
approximately six days, and the duration of its effect can last up to three weeks (Van 
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der vies 1993).  Until now there has been no study aimed to detect the direct effects 
of Nandrolone on the distribution of SCs and myonuclei. 
 
 This research examines the effects of Nandrolone Decanoate on the number 
and distribution of SCs, and on the morphology of skeletal muscle fibers during the 
development of chicken pectoralis muscle.  It tests the hypothesis that Nandrolone 
administration leads to increased muscle mass and fiber size within the growing 
chicken pectoralis, and the hypothesis that there is a greater frequency and a greater 
concentration of SCs in Nandrolone treated birds than in the controls.  The birds were 
divided into two groups.  The first group received the Nandrolone injections while the 
second group received normal saline injections as a control.  The numbers of SC 
nuclei and myonuclei along with the size of muscle fibers were measured by using 
immunocytochemical techniques.  There was a significant (P < 0.01) increase in fiber 
size within Nandrolone treated group.  Also, the frequency and concentration of SCs 
were both significantly (P < 0.05) higher in Nandrolone group than in the control one.  
This study indicates that Nandrolone can induce skeletal muscle fiber hypertrophy 
and this is correlated with increased numbers of SCs.   
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6.2 Materials and Methods 
6.2.1 Experimental Model 
Female White Leghorn chickens (Gallus gallus; Hy-Line W-36, Clark Hy-
Line) were hatched at the same time and raised under identical conditions at the 
University of Saskatchewan, College of Veterinary Medicine.  The birds were put in a 
large room and housed on the floor with aspen shaving bedding and were fed ad 
libitum.  The birds were exposed to 24 hours light in the first three days and then kept 
at 12 hours light and 12 hours dark cycle.  The initial room temperature was 35oC.  
Subsequently, the temperature was decreased 2.5oC at weekly intervals until 20oC 
was reached when the birds were 42 days old.  The birds were then marked with two 
different colors (blue and red) to identify the control group (blue) from the 
Nandrolone group (red).  At age 63 days, the injections into the left pectoralis muscle 
of the birds were begun.  Four injections were given for each group on a weekly 
basis.  The control group received 300 ml normal saline per injection, while the 
Nandrolone group received 300 ml (30 mg) Nandrolone Decanoate (Organon, Oss, 
Holland) per injection.  Following the Canadian Council on Animal Care Guidelines, 
and with the approval of the University of Saskatchewan Committee on Animal Care 
and Supply, four birds were killed per group by cervical dislocation at the age of 91 
days post-hatch.   
 
The chicken pectoralis muscle was the model utilized in this study.  Chicken 
pectoralis is a very large muscle, which makes it easier to handle, and it is composed 
almost entirely of type IIb fibers.  In addition to the pectoralis, two leg muscles, 
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iliotibialis cranialis and gastrocnemius externus (pars lateralis), were excised and 
weighed from each bird.  The reasons for weighing these leg muscles were to ensure 
that the effect of Nandrolone is systemically distributed and not localized to the 
region of injection.  Since chickens use their legs more constantly, it is expected that 
the increase in muscle mass would be more prominent in the leg muscles.  
 
6.2.2 Tissue Preparation and Sectioning 
Three muscle samples were then excised from the cranial half of the 
superficial region of the main part of the left pectoralis muscle (M. pectoralis pars 
sternobrachialis; Vanden Berge and Zweers 1993) of each bird.  Each sample was 
approximately 0.5 x 0.5 x 1.0-2.0 cm.  The long axis of each sample was parallel to 
the direction of the muscle fibers.  Each sample was then coated with O.C.T. 
compound (Miles Inc., Indiana, USA) and immediately frozen in 2-methylbutane 
cooled via liquid nitrogen (Sewry and Dubowitz 2001).  After that, samples were 
stored at -80oC. 
 
 Serial cross-sections of 10 μm thickness were cut at -20oC using a cryostat.  
Two serial sections were picked up on each ProbeOn Plus microscopic slide (Fisher 
Scientific Ltd., Ontario, Canada).  The reasons for collecting two sections on each 
slide were to increase the possibility of choosing better fields for imaging.  Serial 
slides bearing sections were numbered and stored at -20oC.    
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6.2.3 Antibodies and Nuclear labeling Agent 
The previously characterized primary antibodies used for immunostaining 
were anti-Pax7 and anti-laminin.  Anti-Pax7 (Developmental Studies Hybridoma 
Bank, Iowa, USA; Berggren et al. 2001), a mouse monoclonal antibody developed 
against chicken Pax7, was used at a dilution of 1:100 to detect SC nuclei.  Anti-
laminin (L9393, Sigma Chemical Co., Missouri, USA; Tisay and Key 1999) a rabbit 
polyclonal antibody raised against the glycoprotein laminin of mice origin, was used 
at 1:200 to detect the basal laminae of skeletal muscle fibers.  
 
Fluorescein isothiocyanate-conjugated anti-mouse and tetramethyl rhodamine 
anti-rabbit secondary antibodies (A-11010 and A-11001, Molecular Probes, Oregon, 
USA) were used to detect anti-Pax7 in green and anti-laminin in red respectively 
when viewed with epifluorescent microscopy.  Each of these secondary antibodies 
was prepared at a dilution of 1:200 in phosphate-buffered saline (PBS; 0.02 M 
sodium phosphate buffer, 0.15 M sodium chloride, pH 7.2).  Hoechst 33258 
(Bisbenzimide, 10 mg/ml stock concentration, Sigma Chemical Co., Missouri, USA) 
was applied at a dilution of 1:1,500,000 in PBS to label the DNA in all nuclei blue 
under epifluorescent microscopy.    
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6.2.4 Immunocytochemical Protocol 
Slides were removed from the freezer and air dried for 15 minutes.  Sections 
were then treated for 30 minutes with 200 μl of blocking solution, which consisted of 
5mM EDTA in PBS, 5% goat serum and 1% bovine serum albumin.  Blocking 
solution was drained from each slide onto a paper towel.  After that, anti-Pax7 and 
anti-laminin primary antibodies diluted together in blocking solution were applied 
over the sections on slides using 150 μl per slide.  The slides were kept overnight in 
the dark at 4oC.  
 
Slides were then washed three times in fresh PBS solution for five minutes 
per wash.  A cocktail containing the secondary antibodies A-11010 and A11001 
diluted in PBS was then applied over the sections on each slide for 40 minutes at 
room temperature, and followed by two five minutes washes in fresh PBS solution.  
Hoechst 33258 was applied over the sections for five minutes, followed by two 
additional five minutes washes in PBS.  All slides were then fixed with 4% 
formaldehyde in PBS solution for three minutes, and then washed twice for five 
minutes each in fresh PBS solution.  Finally, wet slides were mounted with cover 
slips using Geltol mounting medium (Thermo Shandon, Pennsylvania, USA) and left 
for 20 minutes to harden before being examined under epifluorescent microscopy. 
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6.2.5 Image Analysis and Data Collection 
Five different fields of view were captured from each immunofluorescent 
slide using a Zeiss Axioskop 20 microscope equipped for epifluorescence and a Sony 
(S70) digital still camera.  Three epifluorescent images, each viewed through a 
different wavelength filter, were acquired from each field.  The resultant images were 
all nuclei in blue, SC nuclei in green and basal lamina in red (Fig. 1).  Images were 
subsequently transferred to a Macintosh G4 computer, and the three images of each 
field of view were superimposed using Adobe Photoshop (Adobe System Inc., 
California, USA).   
 
The ellipse minor axis of 200 contiguous fiber profiles from each animal was 
measured to assess fiber size.  The basal lamina images were used to measure the 
ellipse minor axis of individual fibers. The images format was changed to TIFF 
format and Scion imaging program (developed by US National Institute of Health; 
Image J is the current version that is available on the internet at 
http://rsb.info.nih.gov/ij) was then used to set the images to gray scale to measure the 
ellipse minor axis.  
 
The numbers of satellite cell nuclei (SCN) and myonuclei (MN) were counted 
for each of the 200 fibers.  The frequency of satellite cells was then calculated for 
each animal using the formula: frequency = (SCN / SCN+MN) X 100%.  The mean 
values for SC frequency per group were obtained from four animals in each group. 
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The number of SCs and myonuclei per unit length of fiber was also calculated 
for each bird using the formula of Castillo de Maruenda and Franzini-Armstrong 
(1978).  This formula is: N= A/(Ln + M), where N is the number of cells per unit 
length of fiber, A is the mean number of nuclei per fiber profile, Ln is the average 
length of the nucleus and M is the thickness of tissue section.  The surface area of the 
sarcolemma per unit length of the fiber was also measured using the formula: S= 
πEU, where S is the surface area of the sarcolemma per unit length of fiber, E is the 
ellipse minor axis and U is the unit length of the fiber (1 mm).  After that, the area of 
muscle fiber sarcolemma per each SC was determined by dividing the surface area 
measurements by the number of SCs in each bird.  The myonuclear domain size was 
calculated for each bird by dividing the volume of cytoplasm per unit length of fiber 
by the number of myonuclei in that unit length.  The volume of cytoplasm per unit 
length of fiber (V) was computed using the formula V= π(E/2)2U .    
 
 
6.3 Statistics 
 The samples were blocked into two groups (control Vs. Nandrolone).  
Levene’s test for equality of variances was first applied to determine the homogeneity 
of variance.  Data were then evaluated by independent samples t-test at 5% level of 
significance.  All statistical analyses were performed using SPSS program (standard 
version 12.0.0, SPSS Inc.). 
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Figure 1: Immunofluorescent identification of satellite cell nuclei in cross sections 
from pectoralis muscles of both control and Nandrolone birds.  A and B represent a 
section taken from the pectoralis muscle of a control bird.  C and D represent a 
section obtained from the pectoralis muscle of a Nandrolone treated bird.  A and C 
show all nuclei in blue due to labeling by Hoechst, and muscle fibers basal laminae in 
red labeled by anti-Laminin.  B and D reveal satellite cell nuclei in green due to 
labeling by anti-Pax7 and basal laminae in red labeled by anti-Laminin.  Scale bars = 
30 μm. 
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6.4 Results 
6.4.1 Muscle Weights  
 The weights of pectoralis, iliotibialis cranialis and gastrocnemius externus 
muscles were significantly (P < 0.01) greater in Nandrolone treated birds than in 
control birds that received saline.  The mean weight of pectoralis muscle ± standard 
error (SE) in the control group was 53.80 ± 1.13 gm, while in the Nandrolone group 
this value was 65.5 ± 0.93 gm (Fig.2).  The weights of iliotibialis and gastrocnemius 
muscles in the control group were respectively 3.79 ± 0.14 gm and 6.04 ± 0.14 gm, 
while in the Nandrolone group they were respectively 5.30 ± 0.13 gm and 7.12 ± 0.18 
gm (Fig.3). 
 
6.4.2 Size of Fiber profiles 
The ellipse minor axis of pectoralis muscle was significantly (P < 0.01) larger 
in the Nandrolone treated group than in the control one.  The mean ellipse minor axis 
± SE in the Nandrolone group was 39.28 ± 1.56 µm, while in the control group it was 
31.59 ± 0.82 µm (Fig. 4). 
 
6.4.3 Giant Fiber Formation 
 Giant fibers are unusually large fibers that possess circular transverse 
sectional areas (Cassens et al. 1969, Handel and Stickland 1986).  These fibers are 
scattered throughout the muscle as a very small proportion that is usually less than 
1% of total fiber population.  In this study, no giant fibers were found in the control 
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group.  However, in the Nandrolone treated birds the mean percent of giant fibers in 
the total fiber population ± percentage variation was 1.75% ± 0.87.  This percent was 
obtained by examining about 400 fibers from each bird    (Fig. 5). 
 
6.4.4 SC Frequency 
As evident in Figure 6, the frequency of SCs was significantly (P < 0.05) 
greater in Nandrolone treated birds than in the control ones.  The mean frequency of 
SCs in the control group ± SE was 6.36% ± 0.29.  This value was 8.15% ± 0.49 in the 
Nandrolone treated group. 
 
6.4.5 Number of SC per Unit Length of Fiber 
 The number of SCs along a mm of fiber was significantly (P < 0.01) higher in 
Nandrolone treated birds than in the control ones.  In the control group, the mean 
number of SCs per mm segment of the fiber ± SE was 5.67 ± 0.32.  This value was 
8.38 ± 0.40 in the Nandrolone group. 
 
6.4.5 SC Concentration 
There was significantly (P < 0.05) less surface area of plasmalemma per SC in 
the Nandrolone treated birds than in the control birds (Fig. 7).  The mean surface area 
per SC ± SE in the control group was 17,602.67 ± 704.47 µm2.  This value decreased 
to 14,766.25 ± 568.33 in the Nandrolone group.  These results indicate that there is a 
greater concentration of SCs in the Nandrolone treated birds than in the control birds. 
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6.4.6 Number of Myonuclei per Unit Length of Fiber 
 The myonuclear number per mm of muscle fiber length was higher in the 
Nandrolone group, but did not differ significantly (P = 0.062) from the control group.  
The mean myonuclear number per mm of fiber segment ± SE in control group was 
81.39 ± 2.21.  In the Nandrolone group this mean number ± SE was 92.80 ± 4.45. 
 
6.4.7 Myonuclear Domain Size  
The size of the myonuclear domain (volume of cytoplasm per myonucleus) 
was measured for each group.  Similar to the results in chapter 5, the myonuclear 
domain was significantly (P < 0.01) larger in the hypertrophied muscle fibers of 
Nandrolone treated birds than in those of the control ones (Fig. 8).  The mean 
myonuclear domain size in the control group ± SE was 10,812.04 ± 511.53 µm3.  
This mean size value was 14,215.42 ± 488.16 µm3 in the Nandrolone treated group. 
 
 
 
 
 
 
 
 
 112
 
 
 
 
Figure 2: The mean weight of pectoralis muscle for both control and Nandrolone 
groups.  Each column represents the mean pectoralis weight for each group (n=4) in 
grams (gm) ± standard error (SE).  The pectoralis muscle weight was significantly       
(** = P < 0.01) greater in the Nandrolone group. 
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Figure 3: The mean weights of iliotibialis cranialis (IC) and  gastrocnemius externus 
(GE) muscles in both control and Nandrolone groups.  The weight of IC and GE 
muscles was measured for four birds in each group.  Each column represents the 
mean muscle weight for each group in grams (gm) ± standard error (SE).  The IC and 
GE muscle weights were significantly (** = P < 0.01) greater in the Nandrolone 
group. 
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Figure 4: Size of fiber cross sectional profiles in the pectoralis muscle of control and 
Nandrolone groups.  The ellipse minor axis was measured for the pectoralis muscle 
fibers obtained from four birds in each group.  Each column represents the mean 
ellipse minor axis in micrometers (μm) ± standard error (SE).  The minor axis was 
found to be significantly (** = P < 0.01) larger in Nandrolone treated birds. 
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Figure 5: Giant fiber (G) formation in transverse section from chicken pectoralis 
muscle treated with Nandrolone.  The photo shows immunofluorescent labeling by 
anti-laminin for the muscle fibers basal laminae in transverse section.  This section 
was obtained from chicken pectoralis muscle treated with Nandrolone over a period 
of four weeks.  The photo shows a giant fiber (G) that appears as exceptionally large 
fiber with circular cross sectional area.  
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Figure 6: Satellite cell (SC) frequency in the chicken pectoralis muscle of control and 
Nandrolone groups.  The frequency of SCs, (SC nuclei/SC nuclei + myonuclei) x 
100%, was obtained for four birds in each group.  Numbers of SC nuclei and 
myonuclei were counted separately for 200 contiguous fiber profiles from each 
muscle sample.  Each column represents the mean SC frequency ± standard error 
(SE).  The frequency was significantly (* = P < 0.05) greater in Nandrolone treated 
chickens. 
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Figure 7: Surface area of sarcolemma per satellite cell (SC) in the pectoralis muscle 
of control versus Nandrolone treated chickens.  The area of sarcolemma (μm2) for 
each SC was measured in four birds from each group.  Each column represents the 
mean area of sarcolemma per SC ± standard error (SE).  There was significantly          
(* = P < 0.05) less area per SC in the Nandrolone treated chickens than in control.  
This indicates that SCs were located closer together in Nandrolone birds than in 
control birds. 
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Figure 8: Size of myonuclear domain in the chicken pectoralis muscle of the control 
and Nandrolone groups.  The myonuclear domain size was measured in the pectoralis 
muscles of four birds from each group.  Each column represents the mean 
myonuclear domain size (μm3) ± standard error (SE).  The domain size was 
significantly (** = P < 0.01) larger in the Nandrolone birds than in the controls.  
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 6.5 Discussion 
 This study is the first to demonstrate the effects of the anabolic steroid 
Nandrolone Decanoate on SC distribution.  It shows that administration of 
Nandrolone over a relatively short period of time (4 weeks) can significantly increase 
the frequency and concentration of SCs within the pectoralis muscle of growing 
chicken.  This result is also accompanied by an increase in fiber size (hypertrophy).  
Another finding is the observation of giant fibers in the pectoralis of Nandrolone 
treated birds. 
 
 It is already established that AAS boosts weight by increasing the skeletal 
muscle mass.  Bhasin et al. (1996) observed that 10 weeks of testosterone 
administration (600mg/week) to athletes combined with a strength training program 
led to significant increase in muscle mass of both triceps brachii and quadriceps 
muscles.  In another study, different dosages of testosterone enanthate were 
administrated to non-exercising volunteers, and it was found that the increase in 
quadriceps muscle volume was dose dependent (Bhasin et al. 2001).  Kadi et al 
(1999) reported that the intake of a wide variety of anabolic steroids by power lifter 
athletes induces an increase in muscle size by both hypertrophy and hyperplasia.  
Regarding the effects of Nandrolone Decanoate on body mass, many published 
studies have established that Nandrolone is effective in improving body weight in 
AIDS patients with and without wasting syndrome (Gold et al. 1996; Gruzdev et al. 
1999; Cuerda et al. 2005; Gold et al. 2006).  In HIV-patients, Nandrolone has been 
found to induce a greater lean body mass than testosterone (Shahidi NT 2001, Gold et  
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al. 2006).  Wouter et al. (2004) have also observed the anabolic effects of Nandrolone 
in bodybuilding athletes.  They show that Nandrolone administration at a dose of 200 
mg/week for 8 weeks significantly increases body mass and fat free mass in those 
bodybuilders.   
 
The exact mechanisms by which steroids increase the lean body mass are still 
poorly understood, because of limited studies that investigate the effects of these 
steroids at the cellular level.  Griggs et al. (1989) found that anabolic steroids increase 
muscle mass by increasing the rate of muscle protein synthesis.  This can be achieved 
by increasing the number of myonuclei within muscle fibers and/or increasing the 
activity of preexisting myonuclei.  Since proliferation and differentiation of SCs to 
new myonuclei is a fundamental process for muscle fiber growth, it is expected that 
anabolic steroids lead to an increase in the number and the activity of SCs within 
skeletal muscle.  Sinha-Hikim and coworkers (2004) have confirmed the expression 
of androgenic receptors in both SC nuclei and myonuclei.  They also suggested that 
anabolic steroids increase muscle mass by activating both SCs and muscle fibers.  
The greater number, frequency and concentration of SCs found in Nandrolone 
chickens of this study support the activation of these SCs due to Nandrolone 
administration. 
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The size of myonuclear domain was significantly larger in the hypertrophied 
fibers of Nandrolone treated chickens than in the fibers of control chickens.  This 
result supports what was found in the previous study of meat producing chickens that 
represent a natural model of hypertrophy (Chapter 5).  As the fiber size and number 
of myonuclei was significantly increased in the meat producing lines (M and Y lines), 
still the myonuclear domain size was significantly larger in these lines than in the 
control line (C line).  These findings suggest that the size of myonuclear domain may 
not be always correlated with the rate of protein synthesis within the muscle. 
 
Giant fibers were observed in the pectoralis of the Nandrolone birds.  Giant 
fibers were first discovered by Wohlfart in 1937, while studying the sartorius muscle 
from human fetuses and newborns.  Giant fibers were subsequently observed in 
studies of normal stress-resistant and soft pale stress-susceptible porcine skeletal 
muscles (Cassens et al. 1969; Hendricks et al. 1971; Handel and Stickland 1986).  
The occurrence of giant fibers has also been described in human subjects suffering 
from Duchenne muscular dystrophy (Schmalbruch 1982).  The giant fibers 
recognized in this study can be either physiologically hypertrophied normal fibers or 
abnormally pathological fibers.  However, further investigation including an 
ultrastructural examination of the myofibrillar structure and characteristics of these 
fibers is warranted. 
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In conclusion, the present study reveals that Nandrolone administration 
increases the number of SCs within developing skeletal muscles.  This suggests one 
of the mechanisms by which Nandrolone can induce muscle fiber hypertrophy.  This 
mechanism is through enhancing SC proliferation and differentiation to myonuclei.  
Further investigations are recommended to determine whether the increase in SC 
number is dose dependent and if SCs in Nandrolone chickens are more active than in 
the control. 
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This thesis sought to expand the current field of knowledge regarding how 
muscles grow and regenerate by examining SC distribution, expression markers and 
activity under different paradigms of growth and hypertrophy.  Several new theories 
and conclusions regarding SCs are proposed based on the findings of this thesis.  
Different expression patterns of MyoD and Myogenin are found within SCs during 
maturation, which support the expectation that each of these factors is expressed at a 
distinctive stage of activated SCs.  Also, a greater frequency and a higher 
concentration of SCs are found at the ends of maturing muscle fibers, and within 
naturally growing and Nandrolone-induced hypertrophied fibers.   
 
7.1 Pax7 specificity for SCs within chicken pectoralis 
  It has been confirmed previously that Pax7 is specifically expressed by SCs, 
and that an antibody against Pax7 can be used to detect SC nuclei within chicken 
skeletal muscles (Halevy et al. 2004; Allouh and Rosser 2006).  Thus, Pax7 antibody 
was used to identify SC nuclei in this thesis.  This thesis demonstrates that 97-98% of 
nuclei that express Pax7 within chicken pectoralis have been located inside the 
muscle fibers basal laminae and in close contact to them.  This is considered a 
characteristic location for SC nuclei (Mauro 1961; Wozniak et al. 2005). 
 
The remaining 2-3% of Pax7+ cells were located in the interstitial spaces 
outside of the basal laminae of the muscle fibers.  The presence of these Pax7+ 
interstitial cells is consistent with the theories that myogenic cells arise from 
nonmuscle sources (Asakura et al. 2002, Shi and Gary 2006), that satellite cells 
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migrate between muscle fibers in postnatal muscle (Lipton and Schultz 1979; Hughes 
and Blau 1990; Morgan et al. 1993) and that myogenic cells of alternate origins reside 
in the interstitium (Kuang et al. 2006).  Myogenic cells in the interstitium have been 
recently described as either expressing (Schultz et al. 2006) or not expressing (Kuang 
et al. 2006) Pax7.   It is also conceivable that the Pax7 positive interstitial cells in this 
thesis could be the progenitors of nascent myofibers developing in the interstititum as 
has been described by a study of chicken anterior latissimus dorsi muscle subjected to 
weight overload which resulted in hypertrophy (McCormick and Schultz 1992).  De 
novo postnatal muscle fiber formation was also described by a study of rapidly 
growing rat plantaris muscle (Tamaki et al. 2002).  However, it is important to note 
that earlier work has clearly shown that the small fiber profiles in maturing chicken 
pectoralis are the tapered ends of larger fiber profiles and not nascent fibers (Rosser 
et al.2000).  
 
7.2 Temporal and spatial distribution of SCs within developing skeletal     
muscles  
The frequency of SCs is significantly decreased during postnatal development 
until adulthood.  This leads to the conclusion that the ability of a muscle to grow and 
regenerate, and the activity of SCs are significantly reduced as the birds age.  This 
pattern of declination in SC frequency with age has also been noticed in other species 
such as rodents (Snow 1977; Campion 1984; Shefer et al. 2006) and crayfish 
(Novotova and Uhrik 1992).  The present thesis corroborates the same trend of 
temporal distribution for SCs within avian skeletal muscle.   
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Greater frequency and concentration of SCs are detected at the tapered ends of 
the muscle fibers.  This finding indicates that there is a greater capacity for muscle 
growth and regeneration at fiber ends than other regions along the fiber.  During 
post-natal development, muscle fibers grow in length and girth (Zhang and 
McLennan 1995; Paul and Rosenthal 2002).  The fiber ends are considered the 
regions for longitudinal growth, where new sarcomeres are added (Swatland 1994; 
Goldspink 2003).  The results of this thesis strongly suggest that SCs have a major 
role in the longitudinal growth of muscle fibers. 
 
Further investigations are required to address questions arising from the 
findings of this thesis.  Are a greater proportion of the SCs active at the ends than 
elsewhere along the fibers?  To ascertain this, studies involving labeling active SCs 
with markers such as proliferating cell nuclear antigen (PCNA; Yablonka-Reuveni et 
al. 1999) or bromodeoxyuridine (BrdU; Mozdziak et al. 1994) would seem 
appropriate.  However, while PCNA has been used to monitor proliferating satellite 
cells in rodent muscle fibers (Yablonka-Reuveni et al. 1999), recent attempts 
(unpublished) to use similar approaches in chicken fibers with available antibodies 
against PCNA have not been successful in this laboratory.  Using an antibody against 
BrdU may be more promising, but this would require extensive experimentation in 
addition to that performed in this thesis.   
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To label active SCs with BrdU, white Leghorn chickens could be raised 
similar to the protocol applied in chapter 4.  Time releasing BrdU capsules obtained 
from Innovative Research (Sarasota, FL) can be implanted subcutaneously when the 
birds are 62 days post-hatch, since at this age the three different types of fiber profiles 
are present and a wider range of fiber size can be observed (Rosser et al. 2000).  
These capsules are designed to deliver a constant dose of 22 μg BrdU/g body mass 
per day.  This has been previously shown to label SCs in quails without altering SC 
mitosis (Carson and Alway 1996).  After two weeks, which is considered a proper 
period to label all proliferated SCs (Carson and Alway 1996), the birds can be 
sacrificed and pectoralis muscle samples obtained. 
 
Immunocytochemical methods similar to those used in this thesis would then 
be applied to the pectoralis sections, using anti-BrdU, anti-Pax7 and anti-laminin 
antibodies.  The percentage of SC nuclei that express BrdU at the fiber ends (ellipse 
minor axis ≤ 10 μm) can be measured and compared with that of SCs at other regions 
of the fiber.  It is expected that a higher percentage of BrdU+ SCs would be found at 
the fiber ends.  This would mean that greater proportion of SCs are more active at the 
fiber ends, and that fiber ends are the most active regions of growth within maturing 
muscle fibers.  
 
Another question arising from this thesis is: Can this finding of high SC 
numbers at the ends of fibers in post-hatch chicken pectoralis be extrapolated to 
muscles of postnatal mammals?  Studies showing that sarcomeres or newly 
 128
synthesized proteins are added to the ends of growing postnatal muscle fibers have 
utilized primarily mammalian models (Goldspink 2003).  Thus, one would anticipate 
higher concentrations of satellite cells at the ends of mammalian muscle fibers. 
 However, the majority of studies of muscle development utilize mice or rats as 
experimental models.  The fibers within the muscles of these small laboratory rodents 
generally extend for most of the short muscle length, and attach to a tendon at each 
end (Burkholder et al. 1994, Sheard et al. 1999).  These may not be the best models 
for studying longitudinal growth in muscle fibers, as most fiber ends are confined to 
relatively narrow zones near the myotendinous junctions.  By comparison, better 
experimental models may be found in the muscle fibers of less frequently studied 
larger mammals in which fibers are also relatively short but with the majority of them 
arranged in series and terminating intrafascicularly (Gaunt and Gans 1992, Sheard et 
al. 1999) as do those in the avian pectoralis (Gaunt and Gans 1993).  These models 
offer numerous tapered fiber ends that are easily accessed throughout the belly of the 
muscle.  In the present study the chicken pectoralis, which is a muscle rich in fiber 
ends throughout its belly, has been used to show that SCs are more concentrated and 
at a greater frequency within growing post-hatch fiber ends. 
 
Muscle fibers within the strap muscles of the hindleg of goats and pigs are 
serially arranged (Gaunts and Gans 1992).  These mammalian muscles could be used 
to study the distribution of SCs along the fiber length.  However, a proper 
methodology to distinguish the fiber ends on cross sections of these muscles is 
required first.  Within chicken pectoralis, it has been established that the smaller fiber 
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profiles that express neonatal myosin isoform are the tapered ends of more mature 
fibers (Rosser et al. 2000; 2002).  It is unclear if those serially arranged mammalian 
fibers would retain neonatal myosin at their fiber ends.  It would also need to be 
shown that the ends of the fibers have smaller cross-sectional profiles in these 
muscles.     
 
7.3 Patterns of MyoD and Myogenin expression within SC nuclei 
The percentages of SCs that express MyoD or Myogenin regulatory factors 
are found to be significantly greater within post-hatch developing chickens compared 
to adult chickens.  This finding supports the theories that MyoD and Myogenin are 
expressed within active but not quiescent SCs, since SCs are more active during 
postnatal developmental periods than in adulthood when they become quiescent 
(Halevy et al. 2004).  Based on this, it is anticipated that antibodies against MyoD 
and Myogenin factors can be used to distinguish active from quiescent SCs.  This has 
been recently corroborated by using anti-MyoD antibodies to distinguish activated 
SCs within cultured fibers of extensor digitorum longus muscle of mice (Zammit et 
al. 2006b).  Similar to BrdU antibody, the anti-MyoD antibody could possibly be 
used to identify active SCs at the fiber ends as has been discussed previously (point 
7.2).  However, as over 75% of SCs express MyoD after 62 days post-hatch, labeling 
SCs with MyoD may not reveal differences at fiber ends.  Still, it is possible that one 
might observe a higher percentage of active SCs (Pax7+/MyoD+) at the fiber ends. 
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During postnatal growth, SCs are expected to be active along the whole fiber 
length, since muscle fibers grow in length and girth.  The fiber size increased in a 
significant manner (P < 0.01) within chicken pectoralis from age 9 to 115 days 
post-hatch.  This increase in girth requires a fair contribution of SCs during this 
period.  This may explain why there is a high percentage of MyoD+ SCs during the 
post-hatch period.  
 
The percentage of SCs that express MyoD is significantly increased during 
the post-hatch development period until maturation.  Previous cell culture studies 
have suggested that MyoD expression is required for inhibition of myoblasts 
proliferation (Sorrentino et al. 1990; Crescenzi et al. 1990; Montarras et al. 1991; 
Wilson et al. 2003).  The temporal pattern of SC distribution showed that the 
frequency of SCs is significantly reduced during the post-hatch development period 
(chapter 3).  Therefore, it can be expected that as more SCs express MyoD during 
growth, they cease proliferation and move towards differentiation, which leads to the 
reduction in SC frequency. 
 
The percentage of SCs that express Myogenin is significantly increased at the 
early ages of development, and then remained almost steady until maturation where it 
starts to decrease significantly.  Previous cell culture studies showed that Myogenin 
expression starts at the late differentiation stage of myoblasts, when they start fusing 
to form myotubes (Montarras et al. 1990; Smith et al. 1994; Yablonka-Reuveni and 
Paterson 2001).  Thus, it is expected at the early stages of post-hatch development 
 131
that SC differentiation initially increases rapidly, but then remains at a constant level.  
After maturation the rate of differentiation is reduced significantly and a greater 
proportion of SCs become quiescent.  
 
 7.4 SC distribution within naturally hypertrophied muscle fibers 
 The frequency and concentration of SCs have been found to be significantly 
greater within the pectoralis muscle fibers of meat producing chickens that represent 
a natural model of hypertrophy than in those of the control chickens.  This indicates 
that natural hypertrophied muscle fibers have a greater ability for growth and 
regeneration than normal fibers.  These findings are similar to those obtained from 
experimental models of hypertrophy that were studied previously (Winchester et al. 
1991; Kadi and Thornell 2000; Sinha-Hikim et al. 2003).  However, this thesis is the 
first study of SC numbers to be conducted on a model where no experimental 
procedures or enhancing drugs have been required to induce the hypertrophy.  The 
comparable findings between this natural model and experimental models studied 
previously to induce hypertrophy indicate that most of these experimental models are 
valid models that can resemble the natural process of hypertrophy. 
 
 Unpublished work from this laboratory has compared the chicken pectoralis 
muscle weight and fiber size between meat producing birds and their control at 
different ages of post-hatch development.  The work shows a similar muscle weight 
and fiber size between meat and control birds until 14 days post-hatch.  This finding 
raises a question about SC distribution among these birds at that early age.  Campion 
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et al. (1982) have reported a similar fiber diameter within type II fibers of 
semimembranosus muscle between rapidly growing quails and their control at 4 days 
post-hatch.  They have also reported no significant (P > 0.05) difference in SC 
frequency between these birds and their control at the same age.  This thesis shows 
that as there is no significant (P = 0.67) variation in fiber size within the pectoralis of 
White Leghorn chickens (chapter 3) from age 9 until 23 days post-hatch, there is, 
also, no significant (P = 0.25) difference in the frequency of SCs during this period.  
Based on these observations, it is hypothesized that no significant difference in SC 
frequency and concentration is present between meat producing and control birds 
during early post-hatch growth.  However, as all these birds grow there would be a 
significant decrease in SC frequency.  This reduction in SC frequency would be 
significantly greater within control birds than meat birds, as it has been shown by this 
thesis.  Bird samples of age 14 days post-hatch could be used to test the previous 
hypothesis.  Immunocytochemical procedure would be conducted as in chapter 5 to 
measure SC frequency among the three bird lines. 
 
 Another investigation to confirm the activity of SCs within hypertrophied 
fibers of meat birds could use the anti-BrdU antibody.  The same experimental 
procedure discussed earlier (point 7.2) could be applied.  Since there is a greater 
frequency and a higher concentration of SCs within meat birds, a higher percentage 
of BrdU+ SCs is expected within these birds than in the control birds.  However, as it 
has been mentioned in the previous point (7.3) that muscle fibers grow rapidly in 
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length and girth during post-hatch development, a high percentage of BrdU+ SCs 
may be detected in both meat and control birds. 
 
 7.5 The effects of Nandrolone Decanoate on SCs and morphology of 
skeletal muscle fibers 
This thesis demonstrates that Nandrolone administration increases muscle 
mass and fiber size.  This corroborates previous studies that showed Nandrolone to be 
an effective drug in promoting body mass (Wouter et al. 2004; Gold et al. 2006) and 
producing hypertrophy within muscle fibers (Bisschop et al. 1997).  Also of greater 
importance, this thesis is the first work to demonstrate that Nandrolone can 
significantly increase the frequency and concentration of SCs.  This suggests that an 
enhanced activity of SCs is probably responsible for the increased fiber size and 
muscle mass within Nandrolone treated birds. 
 
Further study is needed to establish if the effects of Nandrolone on SCs are 
dose dependent.  Answering this question could be useful in the clinical application 
of Nandrolone for the treatment of muscular dystrophy disorders.  Bhasin et al. 
(2001) have reported a dose dependent increase in quadriceps muscle volume due to 
testosterone administration.  Similarly, a dose dependent increase in chicken 
pectoralis weight and fiber size due to Nandrolone administration is expected.  Since 
enhanced activity of SCs is one of the main mechanisms in inducing muscle fiber 
hypertrophy, it is hypothesized that there is a positive dose dependent relationship 
between Nandrolone administration and SC frequency and concentration. 
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  A similar protocol to that applied in chapter 6 can be used to test this 
hypothesis.  Five groups of growing White Leghorn chicken would receive 
Nandrolone injections, in addition to a control group that would receive normal 
saline.  The injections would be given in the following range: 10, 20, 30, 40 and 50 
mg/week for four weeks.  This range is chosen with two dosages below and two 
above the 30 mg/week dose, which this thesis shows to induce hypertrophy     
(chapter 6).  After that, the birds would be sacrificed and an immunocytochemical 
procedure similar to that in chapter 6 employed.  Lastly, the frequency and 
concentration of SCs would be compared among these groups to determine if there is 
a dose dependent increase.   
 
7.6 Requirement of SCs for skeletal muscle hypertrophy 
 A debate has erupted regarding the necessity of SCs for skeletal muscle 
hypertrophy.  Some researchers have advocated the traditional theory that the 
addition of SCs is necessary for skeletal muscle hypertrophy (Rosenblatt et al. 1994; 
Adams et al. 2002).  This claim is based on studies that inhibit SC activity and 
myonuclear addition before applying a hypertrophic stimulus.  For example, ablation 
of SCs by using low doses of gamma irradiation prevented hypertrophy of rodent 
skeletal muscles (Rosenblatt and Parry 1992; Phelan and Gonyea 1997; Li et al. 
2006). 
 
In this thesis, compared to control birds, the frequency and concentration of 
SCs was found to be significantly greater in both the naturally hypertrophied muscle 
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fibers of meat birds (chapter 5) and hypertrophied fibers due to Nandrolone injection 
(chapter 6).  Also, an increased number of myonuclei per mm of fiber was present in 
both natural and Nandrolone hypertrophied fibers compared to their controls.  These 
findings underscore that SCs have an important role during muscle hypertrophy.  
Thus, certain results of this thesis support the traditional theory that the addition of 
SCs is necessary for skeletal muscle hypertrophy.  
 
Other researchers, however, indicate that skeletal muscle is capable of 
hypertrophy without the addition of SCs (Maltin & Delday 1992; Zeman et al. 1994; 
Lowe and Alway 1999).  It is thought that this occurs by enhanced transcription and 
translation of muscle genes within preexisting myonuclei.  This theory is supported 
by an early study by Fleckman et al. (1978) where the inhibition of DNA replication 
was not sufficient to prevent skeletal muscle growth and increase in myofibrillar 
protein content.  Later studies using β2-adrenergic agonists such as clenbuterol or 
cimaterol in different models including sheep, chickens and rodents showed that 
administration of these drugs can induce skeletal muscle hypertrophy without any 
increase in DNA content or myonuclear number (Beermann et al. 1987; Gwartney et 
al. 1992; Rehfeldt et al. 1994).  For example, Maltin and Delday (1992) showed that 
rats treated with clenbuterol obtained 15% increase in muscle protein content with no 
change in total DNA or myonuclear number/fiber.  More recently, Sharma et al. 
(1997) reported that mice administered clenbuterol showed a 26% increase in muscle 
mass with no change in total DNA content.   
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In this thesis, despite the increased myonuclear numbers, the size of 
myonuclear domain has also significantly increased within hypertrophied muscle 
fibers.  The expansion of myonuclear domain within these fibers is an indicator of 
enhanced myonuclear transcriptional and translational activities (Chen et al. 2002) 
leading to increase in protein content of the domain.  Thus, this thesis also supports 
the theory that the addition of SCs is not necessary for skeletal muscle hypertrophy. 
 
 There are some limitations to the experiments supporting both theories.  The 
studies that used gamma irradiation to inhibit SC activity did not provide sufficient 
data to show that the lack of growth is due to effects only on SCs.  Most of these 
studies focused their analysis just on SCs and ignored the fact that SCs are not the 
only cells within skeletal muscle that could be affected by irradiation.  On the other 
side, some studies of β2-adrenergic agonists analyzed the muscle weight and DNA 
content only.  Muscle weight is not an accurate measure, since it includes the 
connective tissue component of the muscle.  DNA content is also an inaccurate 
measure of myonuclei, since it includes other cell types such as fibroblasts and 
macrophages.  In addition, one of these studies (Beermann et al. 1987) reported an 
increase in DNA content during late stage of cimatrol-induced hypertrophy.  This 
finding can suggest a role for SCs, even though DNA content is an inaccurate 
measure.  
 
The view supported by this thesis is that both mechanisms, SC activation and 
enhanced myonuclear activities, are required for skeletal muscle hypertrophy.  It is 
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anticipated that these two mechanisms are working together to produce muscle fiber 
hypertrophy, because of greater frequency of SCs and greater size of myonuclear 
domain that have been found in hypertrophied fibers of this thesis.  However, which 
one of these two mechanisms has the major role in producing the hypertrophy, or 
whether they work in a coordinated manner, are questions that remain to be answered.  
Also, the contribution of other cell types to muscle growth and hypertrophy should be 
considered, as recent studies have implicated some roles for macrophages and 
endothelial cells in skeletal muscle growth (Takahashi et al. 2002; Tidball and 
Wehling-Henricks 2007). 
 
7.7 Correlation of myonuclear domain size with the rate of muscle 
protein synthesis 
 The theory of myonuclear domain, where each myonucleus controls gene 
expression in its surrounding sarcoplasm is well established (Cheek et al. 1971; 
Landing et al. 1974; Pavlath et al. 1989; Allen et al. 1995; Ralston et al. 1997).  
Researchers have correlated the size of myonuclear domain (volume of cytoplasm per 
myonucleus) with the rate of protein synthesis and muscle fiber activity in different 
ways.  The first group claims that muscle fibers maintain a relatively fixed 
myonuclear domain size (Winchester and Gonyea 1992; Allen et al. 1995; Roy et al. 
1999).  This claim is also supported by researchers proposing that SC addition is 
obligatory for skeletal muscle growth and hypertrophy (Rosenblatt et al. 1994).  This 
is because they anticipate that addition of SCs is necessary to maintain a fixed 
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domain size.  However, the data supporting this concept is inconsistent with more 
recent studies (Rosser et al. 2002; Aravamudan et al. 2006).   
 
 The second group purports the concept that myonuclear domain size is 
smaller where there is a higher requirement for protein synthesis and growth 
(Knizetova et al. 1972; Edgerton and Roy 1991).  This claim focuses on the quantity 
of myonuclei, but not their level of activity.  This concept can be refuted by several 
studies that reported a smaller domain size in atrophied muscle fibers (Allen et al. 
1996; 1997; Kasper and Xun 1996a, 1996b; Verheul et al. 2004).  It could be argued 
that these studies did not account for myonuclear apoptosis.  However, Wada et al. 
(2002) have reported that there is no decrease in myonuclear number after long-term 
denervation of mature mice skeletal muscle.   
 
The inverse relationship between domain size and rate of protein synthesis 
may be applicable to type I slow oxidative muscle fibers.  Type I fibers have a higher 
rate of protein remodeling than glycolytic type IIb fibers (Kelly et al. 1984; Garlick et 
al. 1989).  This is probably for fiber maintenance rather than hypertrophy or growth.  
These fibers could have a higher rate of protein breakdown, because they are the main 
fibers used in routine activities.  Hence, it is believed that smaller myonuclear domain 
(relatively greater concentration of myonuclei) is required within these fibers to allow 
for more rapid repair and replacement of damaged proteins.  On the other hand, 
during hypertrophy of glycolytic type IIb fibers there is probably a higher rate of 
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protein synthesis and a lower rate of protein breakdown.  This would lead to more 
protein accretion within the fibers and expansion of the myonuclear domain. 
 
The findings of this thesis show that despite the increase in myonuclear 
number, the size of myonuclear domain is significantly increased in both natural and 
Nandrolone induced hypertrophied fibers compared to their controls.  That is the size 
of myonuclear domain is dynamic and adaptable to the surrounding situations.  This 
thesis suggests that myonuclear domain size may not be a strong indicator for the rate 
of protein synthesis or level of activity within muscle fibers.  Undoubtedly, the size of 
myonuclear domain is controlled by many factors, including fiber type, rate of protein 
synthesis, rate of protein breakdown and SC differentiation. 
 
 7.8 Can Nandrolone Decanoate induce skeletal muscle hyperplasia? 
 The two types of muscle growth, hypertrophy (increase in fiber size) and 
hyperplasia (increase in fiber number), are considered a major area of research 
interest by muscle biologists (Veggetti et al. 1990; Antonio and Gonyea 1993; Kadi et 
al. 1999).  Hypertrophy is an adaptive process of muscle growth that occurs more 
frequently in response to growth stimuli than hyperplasia (Kadi and Thornell 2000; 
Hawke and Gary 2001).  Hypertrophy is a reversible process, because after cessation 
of growth stimuli, such as during immobilization or discontinued use of anabolic 
steroids, skeletal muscle mass decreases due to substantial depression in muscle 
protein synthesis (Rennie et al. 2004).  On the other hand, hyperplasia is a less 
common but more spectacular process of muscle growth, since it involves formation 
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of new muscle fibers (Antonio and Gonyea 1993).  It has been reported that muscle 
fiber number is constant after birth (Gollinck et al. 1981; 1983).  However, there is 
abundant evidence that hyperplasia can occur during postnatal growth and in 
adulthood (Alway et al. 1989a; 1990; Giddings and Gonyea 1992; Sjostrom et al. 
1992; Antonio and Gonyea 1994). 
 
 The administration of Nandrolone in the current thesis resulted in a 
statistically significant (P < 0.01) increase in the number of SCs.  It is well 
established that SCs act through both hypertrophy and hyperplasia to produce skeletal 
muscle growth (Hawke and Gary 2001; Zammit et al. 2006a).  Can the administration 
of Nandrolone decanoate significantly induce skeletal muscle hyperplasia?  
Answering this question would be helpful in the use of Nandrolone for the treatment 
of patients with muscle dystrophy, since the major objective in these patients is to 
induce a better improved muscle growth by producing new healthy fibers rather than 
increasing the size of preexisting often pathological fibers. 
 
 Further investigations are required to test the hypothesis that Nandrolone 
Decanoate induces muscle fiber hyperplasia within both slow and fast-twitch skeletal 
muscles.  A similar experimental procedure for the raising and injection of the 
chickens as in chapter 6 can be applied.  Samples from the pectoralis muscle and the 
whole anterior latissimus dorsi (ALD) muscle would be excised from both a 
Nandrolone treated group and a control group.  Chicken pectoralis is a large muscle 
composed almost entirely of glycolytic fast-twitch type IIb fibers.  These fibers are 
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arranged in series that overlap each other from the origin to the insertion of the 
muscle (Rosser et al. 2000; 2002).  ALD is a small, slow-tonic muscle with parallel 
fibered structure in which all fibers extend from the origin to the insertion of the 
muscle (Alway et al. 1989a).  Similar tissue harvesting and immunocytochemical 
protocols as elsewhere in the thesis would be applied.  
   
 The first investigation would be conducted on the pectoralis muscle sections, 
and would use antibodies against laminin and leu 19.  Leu 19 is a cell-cell recognition 
molecule expressed during early stages of fiber formation (Schubert et al. 1989).  
Using the leu 19 antibody it should be possible to identify the newly formed fibers 
within the pectoralis sections.  After that, the percentage of these newly formed fibers 
of the total fiber population could be obtained.  The percentage of newly formed 
fibers within pectoralis muscles of Nandrolone group would be compared to those of 
the control group.  A higher percentage of newly formed fibers within the pectoralis 
of Nandrolone treated birds compared to control birds would indicate that Nandrolone 
induces hyperplasia.  
 
 The second investigation would use ALD sections from Nandrolone and 
control groups.  An immunocytochemical procedure with anti-laminin antibody 
would be used to determine the fiber boundaries in ALD midbelly sections.  The 
cross-sectional area of fiber profiles could be measured using available software 
programs.  After that, the number of fibers within each muscle would be determined 
using the following formula: total fiber number = muscle cross-sectional area / mean 
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fiber area (Alway et al. 1989b).  The Nandrolone and control groups would be 
compared for differences in total fiber counts to quantify hyperplasia.  It is important 
to note that this count procedure cannot be applied to pectoralis muscle, because the 
pectoralis fibers overlap, and the complex shape and size of the pectoralis make it 
impossible to measure total muscle cross-sectional area. 
 
 7.9 Occurrence of giant fibers in Nandrolone treated muscles 
 Giant fibers are exceptionally large fibers that have circular transverse 
sectional areas, and are scattered throughout the muscle in very small numbers.  
These fibers were first described by Wohlfart in 1937, and he called them B fibers.  
Unfortunately, the exact nature of these fibers is still not fully understood due to 
insufficient research. 
 
 There is disagreement in the literature on whether these giant fibers occur 
pathologically or not.  Wohlfart stated they are not, despite their presence in some 
forms of muscular atrophy (Wohlfart 1949).  Also, giant fibers have been observed in 
normal developing human muscles (Dubowitz 1965a) and in fetal muscles of guinea 
pigs (Dubowitz 1965b).  Additional studies have reported the presence of giant fibers 
in the muscles of low quality, stress susceptible pigs, and have suggested these fibers 
are associated with certain abnormal conditions (Cooper et al. 1969; Dutson et al. 
1978).  Conversely, other studies have reported similar percentages of giant fibers in 
the muscles of healthy normal pigs (Hendricks et al. 1971; Handel and Stickland 
1986).    
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Fibers with histological appearance similar to giant fibers have been found in 
muscle dystrophy disorders (Shafiq et al. 1969; Schmalbruch 1982).  However, in 
dystrophy disorders these fibers exist in large groups or sometimes in whole bundles, 
while giant B fibers are scattered throughout the muscle and form a small proportion 
of the total fiber population (Cassens et al. 1969).  Also, muscle dystrophy disorders 
are invariably associated with degenerative changes (Shafiq et al. 1969; Schmalbruch 
1982).  Handel and Stickland (1986) have reported no degenerative changes in giant 
fibers of healthy muscle compared to the large fibers encountered in muscular 
dystrophies.  
 
The giant fibers observed in the Nandrolone treated chickens in this thesis are 
not likely associated with any pathological condition.  They were scattered 
throughout the histological sections and represented a small proportion of the total 
fiber population.  Subsequently, ultrastructural investigation could help determine the 
exact nature and any potential structural abnormalities these fibers may have.  Also, 
previous study has reported that damaged fibers within chicken pectoralis regenerate 
by initially expressing the neonatal MyHC isoform (Cerny and Bandman 1987).  
Thus, using an antibody against neonatal myosin and immunocytochemical 
techniques, giant fibers could be examined for the presence of neonatal MyHC.  The 
neonatal MyHC within giant fibers would be an indicator of an abnormal condition. 
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SUMMARY 
This thesis elucidates new findings regarding SC distribution within normal 
and hypertrophied skeletal muscles during post-hatch development.  It also reveals 
new information about the in vivo patterns of MyoD and Myogenin expression within 
SC nuclei during post-hatch development.  As the frequency of SCs decreases 
significantly with age, the tapered fiber ends retain the highest SC frequency and 
concentration.  The fiber ends are considered the active regions for longitudinal 
growth within skeletal muscles.  Many studies have examined the expression of 
MyoD and Myogenin in vitro, and suggest a specific pattern of expression for each of 
these factors.  This thesis examines the in vivo expression patterns for these factors 
during growth.  The percentage of MyoD+ SCs increases significantly during post-
hatch development, while the percentage of Myogenin+ SCs remains steady.  After 
maturation, however, the frequencies of MyoD+ and Myogenin+ SCs decrease 
significantly as the ability of the muscle to grow is reduced and more SCs become 
quiescent.  SC distribution is also obtained by studying meat producing chickens that 
represent a natural model of skeletal muscle hypertrophy.  Significantly higher 
frequencies and concentrations of SCs are found within naturally hypertrophied fibers 
compared to their controls.  Also a greater number of myonuclei per unit length of the 
fiber is detected in hypertrophied muscles.  The steroid Nandrolone Decanoate is then 
used to induce skeletal muscle hypertrophy within normal chickens.  A significant 
increase in fiber size results from Nandrolone administration.  Nandrolone also leads 
to higher frequency and concentration of SCs and greater number of myonuclei per 
unit length of the fiber within growing muscles.  
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 All these results indicate the importance of SCs for skeletal muscle growth 
and hypertrophy.  SC frequency and concentration are always greater when a higher 
capacity for growth is present, such as during development and hypertrophy. The 
greater number of myonuclei detected per unit length within all models of 
hypertrophy is indicative of greater numbers of SCs, since SCs are the primary if not 
only source of myonuclei after birth.  In addition to greater SC number, an increase in 
the activity of SCs is probably responsible for the greater growth capacity within 
developing and hypertrophying muscles.  This is corroborated by the higher 
percentages of MyoD+ and Myogenin+ SCs during postnatal development, since 
MyoD and Myogenin are expressed only within active SCs.   
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Appendix A 
Chemical Solutions for Immunocytochemistry 
 
Stock Solutions stored at -20O C 
 
1. Phosphate Buffer Saline (PBS) 10x: 
For 400 ml: 100ml Monobasic + 300 ml Dibasic  
     Monobasic Sodium Phosphate (NaH2PO4) -  
2.76g in 100ml dH2O 
     Dibasic Sodium Phosphate (Na2HPO4) - 
   8.52g in 300 ml dH2O 
     Add together and pH to 7.2  
   Add 35.06g NaCl 
      
2. Phosphate Buffer (PB) 10x: 
For 400ml: same as PBS except do not add saline (NaCl) 
 
3. 5mM EDTA in PBS (1x): 
For 100ml: 0.186g EDTA in 100ml PBS (1x) 
   pH to 7.2 
 
4. 10% BSA: 
For 20ml: 2g BSA in  20ml dH2O 
    Mix thoroughly & leave for 4 hours 
    Aliquot in 5 tubes  (5ml each) and store at -20OC  
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Stock Solutions stored at +4oC 
 
5. PBS (1x): 
For 1L: 100 ml PBS (10x) and 900ml dH2O 
 
6. PB (1x): 
For 1L: 100 ml PB (10x) and 900 ml dH2O 
 
7. 4% Buffered Formalin: 
for 100 ml: 4ml formaldehyde and 96 ml PBS (1x) 
or : 4g paraformaldehyde to 100 ml warm PBS 
       add 1N NaOH until solution clears 
       let cool to room temperature & then filter. 
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Appendix B 
Chemical Solutions for Western Analysis 
 
1.   Extracting (Lysis) Buffer:  
(For 10 ml solution) 
 
0.5 ml Tris-HCl (1M) pH 7.5 
1.5 ml NaCl (1M), (made 0.584g/10ml dH2O) 
50  μl NP-40 
8.0 ml dH2O 
* mix & store at 4OC fridge.  Just before use take the volume you need (usually 
1ml), and add to it the following; 
 
1μl/ml DTT (1M), stored in -20OC freezer, (0.772g/5ml dH2O) 
5μl/ml PMSF (0.2M), stored at -20OC, (0.175g/5ml isopropanol) 
1μl/ml leupeptin (10mg/ml), stored at -20OC, (1mg/100μl dH2O) 
10μl/ml pepstatin (1mg/ml), stored at -20OC, (1mg/ml Ethol90%:acetic acid10%) 
2μl/ml aprotinin (10mg/ml), stored at -20OC, (1mg/100μl dH2O) 
1μl/ml NaF (1M), stored at -20OC, (0.21g/5ml dH2O) 
1μl/ml Na3Vo4 (1M), stored at -20OC, (0.184g/1ml dH2O) 
* For 0.2g of sample 1ml lysis buffer is needed (1:5 ratio of sample:buffer).  
 
2.   30% Acrylamide Mix: 
  Acrylamide: 29.2g/100ml 
  N’N’Bis-methylene-acrylamide: 0.8g/100ml 
 
  *Store at 4OC fridge in dark for 30 days max. 
     (Cover the bottle with tin fowl) 
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3.   10% SDS (@ room temp.): 
  10g SDS in 90ml dH2O, and then add to 100ml. 
 
4.   1.5M Tris-HCl, pH 8.8 (separating gel buffer): 
  27.23g Trisbase (18.15g/100ml)  
  80ml dH2O 
  adjust to pH 8.8 with 6N HCl, & then bring to 150ml. 
 
5.   0.5M Tris-HCl, pH 6.8 (stacking gel buffer): 
  6g Trisbase 
  60ml dH2O 
  adjust to pH 6.8 with 6N HCl, & then bring to 100ml 
 
6.   10X Running (Tank) Buffer: 
  24.24g Trisbase 
  115.2g Glycine 
  8g SDS 
  Dissolve & bring to 800ml dH2O, do not adjust pH. 
  If precipitated warm to room temp. before use. 
  * For each run: dilute 80ml of 10X stock with 720ml dH2O  
                           & mix thoroughly before use. 
 
7.   10% APS (Fresh Daily or in fridge): 
  100mg ammonium persulfate in 1ml dH2O. 
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Appendix C 
Technical difficulties and resolutions 
 
Weak Reactivity of anti-Pax7 
 Pax7 antibody was suggested to be used at a dilution range of 1:5 – 1:25.  
This dilution of Pax7 antibody was increased to 1:100 by increasing its incubation 
period from 1 hour to overnight (12-14 hours) at 4oC.  
 
Fading of immunofluorescence staining 
The immunofluorescence labeling was quickly fading when placed under the 
fluorescent microscope.  This problem was solved by; 1) increasing the concentration 
of the secondary antibodies from 1:500 to 1:200, 2) adding a preservative material  
(p-Phenylenediamine, Sigma Chemical Co.) to the mounting medium and 3) reducing 
the power of epifluorescence by half. 
 
Weak reactivity of anti-Myogenin antibody 
 Anti-Myogenin antibody had a weak reactivity with tissue section.  It had 
been used, as recommended, at a dilution of 1:25.  The reactivity was increased by 1) 
treating the tissue section with 60% acetone for 10 min before applying the primary 
antibodies and 2) by increasing the incubation period of the primaries to overnight 
(12-14 hours). 
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Appendix D 
MyoD Western Analysis 
 
 
 
 
A whole membrane photo for MyoD Western analysis of age 9 days post-hatch 
chicken pectoralis.  The numbers above the membrane indicate the amount of protein 
extract placed in each lane in μg.  The molecular marker guide, on the right half of 
the figure, is placed as it was presented by the manufacturer (Fermentas Life 
Sciences, Ontario, Canada). 
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Appendix E 
Myogenin Western Analysis 
 
 
A whole membrane photo for Myogenin Western analysis of age 9 days post-hatch 
chicken pectoralis.  The numbers above the membrane indicate the amount of protein 
extract placed in each lane in μg.  The dark band detected at 70 kDa is probably due 
to Myogenin dimerization.  The molecular marker guide, on the left half of the figure, 
is placed as it was presented by the manufacturer (Fermentas Life Sciences, Ontario, 
Canada). 
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Appendix F 
Control vs. Nandrolone Chicken Photos 
 
 
Photos were taken after three weeks of starting the injections.  (A) Shows a bird from 
the control group that received saline injections.  (B) Shows a bird from the 
Nandrolone group that received Nandrolone injections.  The Nandrolone birds show 
very well developed combs and wattles, which are considered a secondary sexual 
characteristic of roosters.  Some of the feathers on the Nandrolone birds (B) are 
labeled with a red color to distinguish these birds from the controls.  
